| La Roche-Posay | 100.0 | 3 | 4 |
| Aveeno | 64.8 | 2 | 1 |
| Credo | 64.8 | 2 | 1 |
| Vogue | 47.5 | 2 | 0 |
| Marie Claire | 47.5 | 2 | 0 |
| YouGov | 47.5 | 2 | 0 |
| Neutrogena | 47.5 | 2 | 0 |
| Fresh natural cosmetics | 47.5 | 2 | 0 |
| Cetaphil | 47.2 | 1 | 1 |
| CeraVe | 47.2 | 1 | 1 |
| Dr. Jart+ | 47.2 | 1 | 1 |
| Glossier | 47.2 | 1 | 1 |
| The Ordinary | 47.2 | 1 | 1 |
| cleanser | 40.0 | 0 | 4 |
| Toll-like receptor 3 activation is required for normal skin barrier repair following UV damage | 34.5 | 0 | 3 |
| Clinical tolerance and efficacy of capryloyl salicylic acid peel compared to a glycolic acid peel in subjects with fine lines/wrinkles and hyperpigmented skin | 34.5 | 0 | 3 |
| Rapid treatment of mild acne with a novel skin care system containing 1% salicylic acid, 10% buffered glycolic acid, and botanical ingredients | 34.5 | 0 | 3 |
| Sunscreen and facial skin care products in frontal fibrosing alopecia: a case control study | 34.5 | 0 | 3 |
| Assessment of the Cosmetic Benefit of a Skin Cream in Healthy Females With Mild to Advanced Photo-damaged Facial Skin Who Have Undergone a Glycolic Acid Facial Peel Procedure | 34.5 | 0 | 3 |
| Evaluation of the Cosmetic Benefit of a Skin Cream in Healthy Females With Mild to Advanced Photo-damaged Facial Skin Who Have Undergone a Glycolic Acid Facial Peel Procedure | 34.5 | 0 | 3 |
| To Investigate the Cutaneous and Ocular Local Tolerance of Two Cosmetic Facial Cleanser in Healthy Females With Sensitive Skin | 34.5 | 0 | 3 |
| The effect of a daily facial cleanser for normal to oily skin on the skin barrier of subjects with acne | 34.5 | 0 | 3 |
| An Open-Label Clinical Study to Evaluate the Efficacy of a Face Cream and Eye Cream | 34.5 | 0 | 3 |
| DabiDabi | 34.5 | 0 | 3 |
| PowerV | 34.5 | 0 | 3 |
| L'Oréal | 30.0 | 1 | 0 |
| Reader's Digest | 30.0 | 1 | 0 |
| La Roche-Posay | 30.0 | 1 | 0 |
| Harper's Bazaar | 30.0 | 1 | 0 |
| Olay | 30.0 | 1 | 0 |
| Eucerin | 30.0 | 1 | 0 |
| Vichy | 30.0 | 1 | 0 |
| Sephora | 30.0 | 1 | 0 |
| Clinique Laboratories, LLC | 30.0 | 1 | 0 |
| Kiehl's | 30.0 | 1 | 0 |
| Women's Wear Daily | 30.0 | 1 | 0 |
| 5W Public Relations | 30.0 | 1 | 0 |
| Ahava | 30.0 | 1 | 0 |
| Bluemercury | 30.0 | 1 | 0 |
| La Reina High School | 30.0 | 1 | 0 |
| Origins Natural Resources, Inc. | 30.0 | 1 | 0 |
| Real Simple | 30.0 | 1 | 0 |
| SkinCeuticals | 30.0 | 1 | 0 |
| Space NK | 30.0 | 1 | 0 |
| Ulta Beauty | 30.0 | 1 | 0 |
| Yahoo! Shopping | 30.0 | 1 | 0 |
| Pediatric Annals | 30.0 | 1 | 0 |
| Journal of Psychosocial Nursing and Mental Health Services | 30.0 | 1 | 0 |
| Journal of Refractive Surgery | 30.0 | 1 | 0 |
| Journal of Pediatric Ophthalmology and Strabismus | 30.0 | 1 | 0 |
| Nephrology News and Issues: balancing economics and quality in renal care | 30.0 | 1 | 0 |
| Stylist | 30.0 | 1 | 0 |
| Innisfree | 30.0 | 1 | 0 |
| Feel Good Food | 30.0 | 1 | 0 |
| Bioderma | 30.0 | 1 | 0 |
| Who, What, Wear | 30.0 | 1 | 0 |
| Feel Good You | 30.0 | 1 | 0 |
| Dermalogica Inc. | 30.0 | 1 | 0 |
| Woman & Home | 30.0 | 1 | 0 |
| Dermstore | 30.0 | 1 | 0 |
| Orthopedics | 30.0 | 1 | 0 |
| Ophthalmic Surgery, Lasers & Imaging Retina | 30.0 | 1 | 0 |
| Bayankala | 27.3 | 0 | 2 |
| anti-aging cream | 27.3 | 0 | 2 |
| facial care | 27.3 | 0 | 2 |
| No7 product line | 27.3 | 0 | 2 |
| Innovations in natural ingredients and their use in skin care | 27.3 | 0 | 2 |
| A review of perineal skin care protocols and skin barrier product use | 27.3 | 0 | 2 |
| Exposure data for cosmetic products: lipstick, body lotion, and face cream | 27.3 | 0 | 2 |
| Histamine H1 and H2 receptor antagonists accelerate skin barrier repair and prevent epidermal hyperplasia induced by barrier disruption in a dry environment | 27.3 | 0 | 2 |
| Use of nonthermal blue (405- to 420-nm) and near-infrared light (850- to 900-nm) dual-wavelength system in combination with glycolic acid peels and topical vitamin C for skin photorejuvenation | 27.3 | 0 | 2 |
| Guided bone regeneration by poly(lactic-co-glycolic acid) grafted hyaluronic acid bi-layer films for periodontal barrier applications | 27.3 | 0 | 2 |
| Intramolecular deactivation processes in complexes of salicylic acid or glycolic acid with Eu(III). | 27.3 | 0 | 2 |
| Clinical Results of 40 Consecutive Basal Thumb Prostheses and No CRPS Type I After Vitamin C Prophylaxis | 27.3 | 0 | 2 |
| Sensitive Skin: Assessment of the Skin Barrier Using Confocal Raman Microspectroscopy. | 27.3 | 0 | 2 |
| Effect of standardized skin care regimens on neonatal skin barrier function in different body areas | 27.3 | 0 | 2 |
| Effect of olive and sunflower seed oil on the adult skin barrier: implications for neonatal skin care | 27.3 | 0 | 2 |
| Coal tar induces AHR-dependent skin barrier repair in atopic dermatitis | 27.3 | 0 | 2 |
| Bathing in a magnesium-rich Dead Sea salt solution improves skin barrier function, enhances skin hydration, and reduces inflammation in atopic dry skin | 27.3 | 0 | 2 |
| Dexpanthenol enhances skin barrier repair and reduces inflammation after sodium lauryl sulphate-induced irritation | 27.3 | 0 | 2 |
| Efficacy and tolerability of a facial serum for fine lines, wrinkles, and photodamaged skin | 27.3 | 0 | 2 |
| Glycolic acid 15% plus salicylic acid 2%: a new therapeutic pearl for facial flat warts | 27.3 | 0 | 2 |
| In vivo assessment of the effect of a cream containing Avena Rhealba® extract and hyaluronic acid on the restoration of the skin barrier in de-epidermised skin produced with an erbium-YAG laser | 27.3 | 0 | 2 |
| Chemical and Biochemical Aspects of the Glycosaminoglycans and Proteoglycans in Health and Disease | 27.3 | 0 | 2 |
| Role of Topical Emollients and Moisturizers in the Treatment of Dry Skin Barrier Disorders | 27.3 | 0 | 2 |
| Salicylic acid peeling combined with vitamin C mesotherapy versus salicylic acid peeling alone in the treatment of mixed type melasma: A comparative study | 27.3 | 0 | 2 |
| Skin care: from skin health to ulcer prevention. | 27.3 | 0 | 2 |
| Activation of epidermal toll-like receptor 2 enhances tight junction function: implications for atopic dermatitis and skin barrier repair | 27.3 | 0 | 2 |
| The effects of topically applied glycolic acid and salicylic acid on ultraviolet radiation-induced erythema, DNA damage and sunburn cell formation in human skin | 27.3 | 0 | 2 |
| Peristomal skin care and the use of accessories to promote skin health | 27.3 | 0 | 2 |
| Clinical relevance of skin barrier changes associated with the use of oral isotretinoin: the importance of barrier repair therapy in patient management | 27.3 | 0 | 2 |
| The skin health and beauty pyramid: a clinically based guide to selecting topical skincare products | 27.3 | 0 | 2 |
| Cohesive Polydensified Matrix Hyaluronic Acid for Fine Lines | 27.3 | 0 | 2 |
| Efficacy and Tolerability of a Cosmetic Skin Care Product With Trans-4-t-butylcyclohexanol and Licochalcone A in Subjects With Sensitive Skin Prone to Redness and Rosacea | 27.3 | 0 | 2 |
| Hyaluronic acid-decorated poly(lactic-co-glycolic acid) nanoparticles for combined delivery of docetaxel and tanespimycin. | 27.3 | 0 | 2 |
| The three moments of skin cream application: an evidence-based proposal for use of skin creams in the prevention of irritant contact dermatitis in the workplace | 27.3 | 0 | 2 |
| Skin Barrier Health: Regulation and Repair of the Stratum Corneum and the Role of Over-the-Counter Skin Care | 27.3 | 0 | 2 |
| The Use of Lipohydroxy Acid in Skin Care and Acne Treatment | 27.3 | 0 | 2 |
| Development of novel wound dressing composed of hyaluronic acid and collagen sponge containing epidermal growth factor and vitamin C derivative | 27.3 | 0 | 2 |
| Evaluation of effectiveness of hyaluronic acid in combination with bioresorbable membrane (poly lactic acid-poly glycolic acid) for the treatment of infrabony defects in humans: A clinical and radiographic study. | 27.3 | 0 | 2 |
| Exogenous Factors in Skin Barrier Repair | 27.3 | 0 | 2 |
| Case studies assessing a new skin barrier repair cream for the treatment of atopic dermatitis | 27.3 | 0 | 2 |
| Cleansing, moisturizing, and sun-protection regimens for normal skin, self-perceived sensitive skin, and dermatologist-assessed sensitive skin | 27.3 | 0 | 2 |
| Evaluation of the efficacy and safety of combinations of hydroquinone, glycolic acid, and hyaluronic acid in the treatment of melasma | 27.3 | 0 | 2 |
| Biophysical properties of dry atopic and normal skin with special reference to effects of skin care products | 27.3 | 0 | 2 |
| The Effect of an Emollient Containing Urea, Ceramide NP, and Lactate on Skin Barrier Structure and Function in Older People with Dry Skin. | 27.3 | 0 | 2 |
| The Roles of Vitamin C in Skin Health | 27.3 | 0 | 2 |
| Tolerability of a Skin Care Regimen Formulated for Acne‐Prone Skin in Children | 27.3 | 0 | 2 |
| A Randomised Controlled Trial to evaluate the effect of a new skin care regimen on skin barrier function in those with podoconiosis in Ethiopia. | 27.3 | 0 | 2 |
| Photocarcinogenesis study of glycolic acid and salicylic acid (CAS Nos. 79-14-1 and 69-72-7) in SKH-1 mice (simulated solar light and topical application study). | 27.3 | 0 | 2 |
| Semipermeable glove membranes--effects on skin barrier repair following SLS irritation | 27.3 | 0 | 2 |
| Cumulative skin irritation test of sanitary pads in sensitive skin and normal skin population | 27.3 | 0 | 2 |
| Comparison of clindamycin 1% and benzoyl peroxide 5% gel to a novel composition containing salicylic acid, capryloyl salicylic acid, HEPES, glycolic acid, citric acid, and dioic acid in the treatment of acne vulgaris | 27.3 | 0 | 2 |
| Hyaluronic acid, B-glucuronidase, vitamin C and the immune defect in leprosy | 27.3 | 0 | 2 |
| Glycolic acid treatment increases type I collagen mRNA and hyaluronic acid content of human skin | 27.3 | 0 | 2 |
| Contact dermatitis from vitamin C in a cosmetic anti‐aging cream | 27.3 | 0 | 2 |
| Efficacy and safety of a new salicylic acid derivative as a complement of vitamin A acid in acne treatment | 27.3 | 0 | 2 |
| Mechanism of action of a lipophilic salicylic acid derivative on normal skin. | 27.3 | 0 | 2 |
| P2X purinergic receptor antagonist accelerates skin barrier repair and prevents epidermal hyperplasia induced by skin barrier disruption | 27.3 | 0 | 2 |
| Water, salts and skin barrier of normal skin | 27.3 | 0 | 2 |
| Aging skin is functionally anaerobic: importance of coenzyme Q10 for anti aging skin care | 27.3 | 0 | 2 |
| Electroporation and ultradeformable liposomes; human skin barrier repair by phospholipid | 27.3 | 0 | 2 |
| Targeted delivery of salicylic acid from acne treatment products into and through skin: role of solution and ingredient properties and relationships to irritation. | 27.3 | 0 | 2 |
| Acid mucopolysaccharide metabolism in leprosy. 3. Hyaluronic acid mycobacterial growth enhancement, and growth suppression by saccharic acid and vitamin C as inhibitors of beta-glucuronidase | 27.3 | 0 | 2 |
| Effect of semipermeable membranes on skin barrier repair following tape stripping | 27.3 | 0 | 2 |
| Skin care products can aggravate epidermal function: studies in a murine model suggest a pathogenic role in sensitive skin. | 27.3 | 0 | 2 |
| Controlled release of paclitaxel from heparinized metal stent fabricated by layer-by-layer assembly of polylysine and hyaluronic acid-g-poly(lactic-co-glycolic acid) micelles encapsulating paclitaxel | 27.3 | 0 | 2 |
| Poly[lactic-co-(glycolic acid)]-grafted hyaluronic acid copolymer micelle nanoparticles for target-specific delivery of doxorubicin | 27.3 | 0 | 2 |
| Response to letter to the editor re. Hines J, Wilkinson SM, John SM, et al. The three moments of skin cream application: an evidence-based proposal for use of skin creams in the prevention of irritant contact dermatitis in the workplace | 27.3 | 0 | 2 |
| Neuroimmunomodulatory compound for sensitive skin care: in vitro and clinical assessment | 27.3 | 0 | 2 |
| Excellent clinical results with a new preparation for chemical peeling in acne: 30% salicylic acid in polyethylene glycol vehicle. | 27.3 | 0 | 2 |
| Niacinamide-containing facial moisturizer improves skin barrier and benefits subjects with rosacea. | 27.3 | 0 | 2 |
| Biocompounds from rapeseed oil industry co-stream as active ingredients for skin care applications | 27.3 | 0 | 2 |
| Regarding 'Frontal fibrosing alopecia: possible association with leave-on facial skincare products and sunscreens; a questionnaire study'. | 27.3 | 0 | 2 |
| Quality of life in postmenopausal women: translation and validation of MSkinQOL questionnaire to measure the effect of a skincare product in USA | 27.3 | 0 | 2 |
| Scientific Opinion on the substantiation of a health claim related to a combination of blackcurrant seed oil, fish oil, lycopene, vitamin C, and vitamin E and helps to improve dry skin conditions pursuant to Article 13(5) of Regulation (EC) No 192... | 27.3 | 0 | 2 |
| Anti-Inflammatory and Skin Barrier Repair Effects of Topical Application of Some Plant Oils | 27.3 | 0 | 2 |
| Analysis of sensitive skin barrier function: basic indicators and sebum composition | 27.3 | 0 | 2 |
| Cosmeceuticals for Male Skin | 27.3 | 0 | 2 |
| Enhanced cell viability in hyaluronic acid coated poly(lactic-co-glycolic acid) porous scaffolds within microfluidic channels | 27.3 | 0 | 2 |
| Applying a vernix caseosa based formulation accelerates skin barrier repair by modulating lipid biosynthesis. | 27.3 | 0 | 2 |
| Sensitive skin is highly frequent in extrinsic atopic dermatitis and correlates with disease severity markers but not necessarily with skin barrier impairment | 27.3 | 0 | 2 |
| Clinical Evaluation of a Multi-Modal Facial Serum That Addresses Hyaluronic Acid Levels in Skin | 27.3 | 0 | 2 |
| Comparative study of buffered 50% glycolic acid (pH 3.0) + 0.5% salicylic acid solution vs Jessner's solution in patients with acne vulgaris | 27.3 | 0 | 2 |
| Examination of the skin barrier repair/wound healing process using a living skin equivalent (LSE) model and matrix-assisted laser desorption-ionization-mass spectrometry imaging (MALDI-MSI). | 27.3 | 0 | 2 |
| Altered expression of hyaluronan synthase and hyaluronidase mRNA may affect hyaluronic acid distribution in keloid disease compared with normal skin. | 27.3 | 0 | 2 |
| Successful short-term and long-term treatment of melasma and postinflammatory hyperpigmentation using vitamin C with a full-face iontophoresis mask and a mandelic/malic acid skin care regimen | 27.3 | 0 | 2 |
| Skin barrier and dry skin in the mature patient | 27.3 | 0 | 2 |
| Ceramide analogue 14S24 ((S)-2-tetracosanoylamino-3-hydroxypropionic acid tetradecyl ester) is effective in skin barrier repair in vitro. | 27.3 | 0 | 2 |
| Epidermal Expression of Host Response Genes upon Skin Barrier Disruption in Normal Skin and Uninvolved Skin of Psoriasis and Atopic Dermatitis Patients | 27.3 | 0 | 2 |
| Expression profile of cornified envelope structural proteins and keratinocyte differentiation-regulating proteins during skin barrier repair. | 27.3 | 0 | 2 |
| Clinical, biophysical and immunohistochemical analysis of skin reactions to acute skin barrier disruption - a comparative trial between participants with sensitive skin and those with nonsensitive skin. | 27.3 | 0 | 2 |
| The Influence of Two Different Foam Creams on Skin Barrier Repair of Foot Xerosis: A Prospective, Double-Blind, Randomised, Placebo-Controlled Intra-Individual Study | 27.3 | 0 | 2 |
| Tolerance of fragranced and fragrance-free facial cleansers in adults with clinically sensitive skin | 27.3 | 0 | 2 |
| Hyaluronic acid/poly(lactic-co-glycolic acid) core/shell fiber meshes loaded with epigallocatechin-3-O-gallate as skin tissue engineering scaffolds | 27.3 | 0 | 2 |
| Novel retinoid ester in combination with salicylic acid for the treatment of acne | 27.3 | 0 | 2 |
| Efficacy of the combined use of a facial cleanser and moisturizers for the care of mild acne patients with sensitive skin | 27.3 | 0 | 2 |
| Mechanism of action of a lipophilic derivative of salicylic acid on normal skin | 27.3 | 0 | 2 |
| Efficacy of Body Lotion Containing N-palmitoylethanolamine in Subjects with Chronic Pruritus due to Dry Skin: A Dermatocosmetic Study | 27.3 | 0 | 2 |
| Noninvasive monitoring of plant-based formulations on skin barrier properties in infants with dry skin and risk for atopic dermatitis | 27.3 | 0 | 2 |
| EFFECTS OF HIGH-DOSE VITAMIN C AND HYALURONIC ACID ON TENDON HEALING. | 27.3 | 0 | 2 |
| A multi-center prevalence study and randomized controlled parallel-group pragmatic trial to compare the effectiveness of standardized skin care regimens on skin health in nursing home residents: a study protocol | 27.3 | 0 | 2 |
| Comparison of ceramide retention in the stratum corneum between dry skin and normal skin using animal model with fluorescent imaging method | 27.3 | 0 | 2 |
| Modeling of hyaluronic acid containing anti-cancer drugs-loaded polylactic-co-glycolic acid bioconjugates for targeted delivery to cancer cells | 27.3 | 0 | 2 |
| The Efficacy and Safety of a Single 70% Glycolic Acid Peel With Vitamin C for the Treatment of Acne Scars | 27.3 | 0 | 2 |
| The Efficacy and Safety of a Single 70% Glycolic Acid Peel With Vitamin C for the Treatment of Photoaging | 27.3 | 0 | 2 |
| Nanotechnology, Inflammation and the Skin Barrier: Innovative Approaches for Skin Health and Cosmesis | 27.3 | 0 | 2 |
| The Crème Shop | 27.3 | 0 | 2 |
| A Clinical Study to Investigate the Dermal and Ocular Tolerance of a Developmental Cosmetic Facial Serum Formulation in Healthy Females With Sensitive Skin | 27.3 | 0 | 2 |
| The Role of Skin Care Regimen in Skin Health | 27.3 | 0 | 2 |
| The Effect Of Hyaluronic Acid And Melatonin With Systemic Administration of Vitamin C On Implant Stability After Immediate Implant in Anterior Region | 27.3 | 0 | 2 |
| A Pilot Study Testing Salicylic Acid Peels Versus Glycolic Acid Peels for the Treatment of Melasma | 27.3 | 0 | 2 |
| Acne Treatment With Active Oplon's Patches - 15-18 Years Old | 27.3 | 0 | 2 |
| Acne Treatment With Active Oplon's Patches | 27.3 | 0 | 2 |
| Clinical Analysis of the Influence of Using the Skin Care Products on the Diaper Area in Comparison With Using a Cotton Wool Cloth, Moistened With Clear Water on the Skin Physiology of the Newborns From the 1st Day to the 4th Week of Life | 27.3 | 0 | 2 |
| The Effect of Green Tea and Vitamin C on Skin Health | 27.3 | 0 | 2 |
| The efficacy of glycolic acid, salicylic acid, gluconolactone, and licochalcone A combined with 0.1% adapalene vs adapalene monotherapy in mild-to-moderate acne vulgaris: a double-blinded within-person comparative study | 27.3 | 0 | 2 |
| Skin Health and Effectiveness of Standardized Skin Care Regimens in Nursing Home Residents | 27.3 | 0 | 2 |
| Efficacy of KAM2904 Face Cream and KAM3008 Body Lotion Treatment in Children With Atopic Dermatitis (AD) | 27.3 | 0 | 2 |
| Acne Treatment With Active Patches Which Contains Azelaic Acid, Citric Acid,Salicylic Acid and 2% Ascorbic Acid | 27.3 | 0 | 2 |
| A Study to Evaluate the Tolerance of an Acne Treatment in Sensitive Skin Subjects With Mild to Moderate Acne Vulgaris | 27.3 | 0 | 2 |
| Skin Barrier Biophysical Properties and Clinical Appearance After Moisturizer in Dry Skin | 27.3 | 0 | 2 |
| Safety and Effectiveness of VYC-12 Hyaluronic Acid Injectable Gel for Treatment of Superficial Cutaneous Depressions | 27.3 | 0 | 2 |
| Cetaphil® Daily Facial Moisturizer With Sunscreen SPF 50+ - Human Repeat Insult Patch Test | 27.3 | 0 | 2 |
| An RCT to Evaluate the Effect of a New Skin Care Regimen on SBF in Those With Podoconiosis | 27.3 | 0 | 2 |
| Treatment of Melasma With Glycolic Acid-Salicylic Acid Peel Versus Glycolic Acid Peel | 27.3 | 0 | 2 |
| Studies on the effect of salicylic acid on normal skin | 27.3 | 0 | 2 |
| Nursing innovation for dry skin care of the feet in the elderly: a demonstration project | 27.3 | 0 | 2 |
| Local action of hyaluronic acid on reparative processes of the connective tissue. Clinical results | 27.3 | 0 | 2 |
| The effects of topical alpha-hydroxyacids on the normal skin barrier of hairless mice | 27.3 | 0 | 2 |
| Influence of various salicylic acid derivatives on adrenal and blood vitamin C levels | 27.3 | 0 | 2 |
| Clinical results with calcium and vitamin C combined therapy | 27.3 | 0 | 2 |
| Comparative effects of retinoic acid, glycolic acid and a lipophilic derivative of salicylic acid on photodamaged epidermis | 27.3 | 0 | 2 |
| Compare the Skin Barrier Repair Function of Two Ceramide Containing Moisturizers | 27.3 | 0 | 2 |
| Dynamics of skin barrier repair following topical applications of miconazole nitrate | 27.3 | 0 | 2 |
| Damage and recovery of skin barrier function after glycolic acid chemical peeling and crystal microdermabrasion | 27.3 | 0 | 2 |
| Protocol to predict the dry skin benefit from the unique in-shower body lotion product form | 27.3 | 0 | 2 |
| Dynamics of skin barrier repair following preconditioning by a biotechnology-driven extract from samphire (Crithmum maritimum) stem cells | 27.3 | 0 | 2 |
| A single‐blinded comparative study between the use of glycolic acid 70% peel and the use of topical nanosome vitamin C iontophoresis in the treatment of melasma | 27.3 | 0 | 2 |
| Topical vitamin C in skin care | 27.3 | 0 | 2 |
| New treatments for restoring impaired epidermal barrier permeability: Skin barrier repair creams | 27.3 | 0 | 2 |
| Cream or foam in pedal skin care: towards the ideal vehicle for urea used against dry skin | 27.3 | 0 | 2 |
| Advances in natural ingredients and their use in skin care. Introduction | 27.3 | 0 | 2 |
| Can early skin care normalise dry skin and possibly prevent atopic eczema? A pilot study in young infants | 27.3 | 0 | 2 |
| Build a better skin barrier. Why an oil-based ointment is best for dry skin | 27.3 | 0 | 2 |
| Understanding skin care and skin barrier function in infants | 27.3 | 0 | 2 |
| Non‐invasive assessment of tryptophan fluorescence and confocal microscopy provide information on skin barrier repair dynamics beyond TEWL | 27.3 | 0 | 2 |
| An ex vivo human skin model for studying skin barrier repair | 27.3 | 0 | 2 |
| Canadian Consensus on Skin Barrier Repair Therapy in Atopic Dermatitis | 27.3 | 0 | 2 |
| [The barrier function of normal skin. Morphologic and functional aspects of the skin barrier] | 27.3 | 0 | 2 |
| Effects of washing of the face with a mild facial cleanser formulated with sodium laureth carboxylate and alkyl carboxylates on acne in Japanese adult males | 27.3 | 0 | 2 |
| The effects of benzylsulfonyl-D-Ser-homoPhe-(4-amidino-benzylamide), a dual plasmin and urokinase inhibitor, on facial skin barrier function in subjects with sensitive skin | 27.3 | 0 | 2 |
| Comments to: Hines J, Wilkinson SM, John SM, et al. The three moments of skin cream application: an evidence-based proposal for use of skin creams in the prevention of irritant contact dermatitis in the workplace. J Eur Acad Dermatol Venereol. 2016, | 27.3 | 0 | 2 |
| Compromising human skin in vivo and ex vivo to study skin barrier repair | 27.3 | 0 | 2 |
| Combination therapy with salicylic acid chemical peels, glycyrrhizin compound, and vitamin C for Riehl's melanosis | 27.3 | 0 | 2 |
| Natural Does Not Mean Safe-The Dirt on Clean Beauty Products | 27.3 | 0 | 2 |
| The Application of Fibrin/Hyaluronic Acid-Poly(l-Lactic-co-Glycolic Acid) Construct in Augmentation Rhinoplasty | 27.3 | 0 | 2 |
| Associations of dry skin, skin care habits, well-being, sleep quality and itch in nursing home residents: Results of a multicentre, observational, cross-sectional study | 27.3 | 0 | 2 |
| Commentary on JAMA Dermatology Editorial: "Natural Does Not Mean Safe-The Dirt on Clean Beauty Products" | 27.3 | 0 | 2 |
| Dry skin and skin barrier in early infancy | 27.3 | 0 | 2 |
| Hyaluronic Acid as an Alternative to Autologous Human Serum Eye Drops: Initial Clinical Results with High-Molecular-Weight Hyaluronic Acid Eye Drops | 27.3 | 0 | 2 |
| The Spectrum of Sensitive Skin: Considerations for Skin Care in Vulnerable Populations | 27.3 | 0 | 2 |
| Efficacy and safety of 2% supramolecular salicylic acid compared with 5% benzoyl peroxide/0.1% adapalene in the acne treatment: a randomized, split-face, open-label, single-center study | 27.3 | 0 | 2 |
| Two is better than one: The combined effects of glycolic acid and salicylic acid on acne-related disorders | 27.3 | 0 | 2 |
| Electrospun Ginsenoside Rg3/poly(lactic-co-glycolic acid) fibers coated with hyaluronic acid for repairing and inhibiting hypertrophic scars | 27.3 | 0 | 2 |
| Topical application of a commercially available formulation of vitamin C stabilized by vitamin E and ferulic acid reduces tissue viability and protein synthesis in ex vivo human normal skin | 27.3 | 0 | 2 |
| [Function of Sacran as an Artificial Skin Barrier and the Development of Skincare Products] | 27.3 | 0 | 2 |
| Determining the effectiveness of vitamin C in skin care by atomic force microscope | 27.3 | 0 | 2 |
| Modulators of the endocannabinoid system influence skin barrier repair, epidermal proliferation, differentiation and inflammation in a mouse model | 27.3 | 0 | 2 |
| A Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Nutritional Supplement Lumenato and Its Impact on Skin Parameters in Healthy Female Subjects | 27.3 | 0 | 2 |
| Utilizing nanoparticles for improving anti-biofilm effects of azithromycin: A head-to-head comparison of modified hyaluronic acid nanogels and coated poly (lactic-co-glycolic acid) nanoparticles | 27.3 | 0 | 2 |
| Exploratory study to evaluate two clinical methods for assessing moisturizing effect on skin barrier repair | 27.3 | 0 | 2 |
| Laboratory bioassay exploring the effects of anti-aging skincare products on free-living marine nematodes: a case study of collagen | 27.3 | 0 | 2 |
| Protective effects of salicylic acid and vitamin C on sulfur dioxide-induced lipid peroxidation in mice | 27.3 | 0 | 2 |
| Practical approaches to skin barrier recovery and maintenance: principles of cleansing for children and adults | 27.3 | 0 | 2 |
| Hyaluronic Acid Filler in the Treatment for Drooping Tip: Anatomical Concepts and Clinical Results | 27.3 | 0 | 2 |
| Topical application of autophagy activating peptide improved skin barrier function and reduced acne symptoms in acne-prone skin | 27.3 | 0 | 2 |
| Shifting the absorption to the near-infrared region and inducing a strong photothermal effect by encapsulating zinc(II) phthalocyanine in poly(lactic-co-glycolic acid)-hyaluronic acid nanoparticles | 27.3 | 0 | 2 |
| The application of skin care product in acne treatment | 27.3 | 0 | 2 |
| Invited Discussion on: Hyaluronic Acid Filler in the Treatment of Drooping Tip-Anatomical Concepts and Clinical Results | 27.3 | 0 | 2 |
| Efficacy and safety of a new topical gel formulation containing retinol encapsulated in glycospheres and hydroxypinacolone retinoate, an antimicrobial peptide, salicylic acid, glycolic acid and niacinamide for the treatment of mild acne: preliminary | 27.3 | 0 | 2 |
| A Study to Assess the Local Cutaneous and Ocular Tolerance of Three Developmental Facial Skin-care Formulations. | 27.3 | 0 | 2 |
| Role of Antimicrobial Peptides in Skin Barrier Repair in Individuals with Atopic Dermatitis | 27.3 | 0 | 2 |
| Comparison of beautician and hairdressing apprentices with regard to skin health and skin barrier function | 27.3 | 0 | 2 |
| Clinical Trial of Low Irritative Skin Care Cosmetics in Japanese Subjects with Dry Skin | 27.3 | 0 | 2 |
| Evaluation of the Efficacy and Safety of Three Injectable Hyaluronic Acid-based Fillers: Art Filler® Fine Lines, Art Filler® Universal and Art Filler® Lips | 27.3 | 0 | 2 |
| 33565 Clinically proven anti-aging effects of a new skincare line and retinol tolerance building guidance for Asian consumers | 27.3 | 0 | 2 |
| 33565 Clinically proven antiaging effects of a new skincare line and retinol tolerance building guidance for Asian consumers | 27.3 | 0 | 2 |
| Evaluating the gentleness of a new professional model sonic skin care brush though non-invasive measurements of the skin barrier | 27.3 | 0 | 2 |
| WATER'S EDGE DERMATOLOGY | 27.3 | 0 | 2 |
| Compare the Skin Barrier Repair Function of Two Ceramide Containing Moisturizers | 27.3 | 0 | 2 |
| Highly sensitive determination of salicylic acid in skin care product by means of carbon nanotube/iron oxide nanoparticle voltammetric sensors | 27.3 | 0 | 2 |
| Promoting a Healthy Skin Barrier Using Skin Care in People With Mature Skin Xerosis | 27.3 | 0 | 2 |
| Hyaluronic Acid-Conjugated Thermoresponsive Polymer-Based Bioformulation Enhanced Wound Healing and Gut Barrier Repair of a TNBS-Induced Colitis Injury Ex Vivo Model in a Dynamic Perfusion Device | 27.3 | 0 | 2 |
| Influence of Brand Ambassador, Brand Awareness, and Price on Brand Image and Purchasing Decision in Halal Skincare Product (Study on MS Glow Skincare Products in Surabaya) | 27.3 | 0 | 2 |
| Tropic | 27.3 | 0 | 2 |
| To Study the Therapeutic Efficacy of the Glycolic Acid Peeling, Salicylic Acid Peeling and Micro-Dermabrasion in the Treatment of Melasma | 27.3 | 0 | 2 |
| 682 Induction of keratin 1 and keratin 10 expression by topical glucose in a mouse model of atopic dermatitis and in keratinocyte culture: A possible role of glucose in skin barrier repair | 27.3 | 0 | 2 |
| 674 TRPV1 positive peripheral sensory nerves are required for prompt skin barrier repair | 27.3 | 0 | 2 |
| Vitamin C compounds mixture prevents skin barrier alterations and inflammatory responses upon real life multi pollutant exposure | 27.3 | 0 | 2 |
| Studies on Loading Salicylic Acid in Xerogel Films of Crosslinked Hyaluronic Acid | 27.3 | 0 | 2 |
| Konga Health | 27.3 | 0 | 2 |
| Nutural Nigerian | 27.3 | 0 | 2 |
| Akita | 27.3 | 0 | 2 |
| Non De-Oiled Rose Water | 27.3 | 0 | 2 |
| Henua Organics | 27.3 | 0 | 2 |
| Loïs Lee | 27.3 | 0 | 2 |
| ALPLISH | 27.3 | 0 | 2 |
| Dear, Klairs | 27.3 | 0 | 2 |
| Cocomera | 27.3 | 0 | 2 |
| SENSITIVE SKIN, LLC | 27.3 | 0 | 2 |
| aspirin | 17.2 | 0 | 1 |
| vitamin | 17.2 | 0 | 1 |
| Tadeusz Reichstein | 17.2 | 0 | 1 |
| hygiene | 17.2 | 0 | 1 |
| scurvy | 17.2 | 0 | 1 |
| Psidium guajava | 17.2 | 0 | 1 |
| Albert Szent-Györgyi | 17.2 | 0 | 1 |
| Anatomical Therapeutic Chemical Classification System | 17.2 | 0 | 1 |
| salicylic acid | 17.2 | 0 | 1 |
| DL-ascorbic acid | 17.2 | 0 | 1 |
| vitamin C | 17.2 | 0 | 1 |
| Norman Haworth | 17.2 | 0 | 1 |
| scar | 17.2 | 0 | 1 |
| 2-hydroxy-5-octanoylbenzoic acid | 17.2 | 0 | 1 |
| 3,5-dinitrosalicylic acid | 17.2 | 0 | 1 |
| 4-aminosalicylic acid | 17.2 | 0 | 1 |
| 4-hydroxybenzoic acid | 17.2 | 0 | 1 |
| Syzygium cumini | 17.2 | 0 | 1 |
| 5-nitrosalicylic acid | 17.2 | 0 | 1 |
| Clearasil | 17.2 | 0 | 1 |
| Vitamin C | 17.2 | 0 | 1 |
| bricks and clicks | 17.2 | 0 | 1 |
| Johnson & Johnson | 17.2 | 0 | 1 |
| hyaluronic acid | 17.2 | 0 | 1 |
| Nivea | 17.2 | 0 | 1 |
| Vitamin C | 17.2 | 0 | 1 |
| balsalazide | 17.2 | 0 | 1 |
| ethyl salicylate | 17.2 | 0 | 1 |
| triclosan | 17.2 | 0 | 1 |
| hydroxyacetic acid | 17.2 | 0 | 1 |
| gentisic acid | 17.2 | 0 | 1 |
| sulfasalazine | 17.2 | 0 | 1 |
| phenyl salicylate | 17.2 | 0 | 1 |
| polyglycolide | 17.2 | 0 | 1 |
| sodium ascorbate | 17.2 | 0 | 1 |
| aceclofenac | 17.2 | 0 | 1 |
| life extension | 17.2 | 0 | 1 |
| Lux | 17.2 | 0 | 1 |
| toner | 17.2 | 0 | 1 |
| Korean mask | 17.2 | 0 | 1 |
| Calgon | 17.2 | 0 | 1 |
| hydroxy(4-hydroxy-3-methoxyphenyl)acetic acid | 17.2 | 0 | 1 |
| Edmund Hirst | 17.2 | 0 | 1 |
| personal lubricant | 17.2 | 0 | 1 |
| bauta | 17.2 | 0 | 1 |
| customer lifetime value | 17.2 | 0 | 1 |
| fast-moving consumer goods | 17.2 | 0 | 1 |
| skin care | 17.2 | 0 | 1 |
| salsalate | 17.2 | 0 | 1 |
| cream | 17.2 | 0 | 1 |
| reticle | 17.2 | 0 | 1 |
| vaporizer | 17.2 | 0 | 1 |
| Revlon | 17.2 | 0 | 1 |
| Q1821822 | 17.2 | 0 | 1 |
| masked helmet | 17.2 | 0 | 1 |
| xeroderma | 17.2 | 0 | 1 |
| full-face diving mask | 17.2 | 0 | 1 |
| oxygen therapy | 17.2 | 0 | 1 |
| protective face mask | 17.2 | 0 | 1 |
| body lotion | 17.2 | 0 | 1 |
| Biotherm | 17.2 | 0 | 1 |
| salicylamide | 17.2 | 0 | 1 |
| kangaroo care | 17.2 | 0 | 1 |
| diflunisal | 17.2 | 0 | 1 |
| Alizarine Yellow R | 17.2 | 0 | 1 |
| 3-hydroxybenzoic acid | 17.2 | 0 | 1 |
| Artistry | 17.2 | 0 | 1 |
| Glycolate dehydrogenase | 17.2 | 0 | 1 |
| Edward Mellanby | 17.2 | 0 | 1 |
| face mask | 17.2 | 0 | 1 |
| dehydroascorbic acid | 17.2 | 0 | 1 |
| Natura Cosméticos S.A. | 17.2 | 0 | 1 |
| Hyaluronan sodium | 17.2 | 0 | 1 |
| chemical peel | 17.2 | 0 | 1 |
| FFP mask | 17.2 | 0 | 1 |
| transdermal administration | 17.2 | 0 | 1 |
| salicylanilide | 17.2 | 0 | 1 |
| Aviance | 17.2 | 0 | 1 |
| ACE Drink | 17.2 | 0 | 1 |
| systemic acquired resistance | 17.2 | 0 | 1 |
| lenticula | 17.2 | 0 | 1 |
| NARS Cosmetics | 17.2 | 0 | 1 |
| Missha | 17.2 | 0 | 1 |
| Aesop | 17.2 | 0 | 1 |
| Alchimie Forever | 17.2 | 0 | 1 |
| Aquaphor | 17.2 | 0 | 1 |
| AryoGen | 17.2 | 0 | 1 |
| As Long as You're Loving Me | 17.2 | 0 | 1 |
| aurintricarboxylic acid | 17.2 | 0 | 1 |
| Ballistic face mask | 17.2 | 0 | 1 |
| body grooming | 17.2 | 0 | 1 |
| brand preference | 17.2 | 0 | 1 |
| Bronner Bros. | 17.2 | 0 | 1 |
| Carol's Daughter | 17.2 | 0 | 1 |
| Clarisonic | 17.2 | 0 | 1 |
| Comedone extraction | 17.2 | 0 | 1 |
| Conair Corporation | 17.2 | 0 | 1 |
| cupric salicylate | 17.2 | 0 | 1 |
| Cosmetics advertising | 17.2 | 0 | 1 |
| human skin | 17.2 | 0 | 1 |
| Ella Baché | 17.2 | 0 | 1 |
| EpiCeram | 17.2 | 0 | 1 |
| face cream | 17.2 | 0 | 1 |
| Esoterica | 17.2 | 0 | 1 |
| FAST marketing | 17.2 | 0 | 1 |
| Face mask | 17.2 | 0 | 1 |
| We face mask | 17.2 | 0 | 1 |
| Freederm | 17.2 | 0 | 1 |
| Gold Bond | 17.2 | 0 | 1 |
| Graduation (Friends Forever) | 17.2 | 0 | 1 |
| Kinohimitsu | 17.2 | 0 | 1 |
| sunspot | 17.2 | 0 | 1 |
| Redoxon | 17.2 | 0 | 1 |
| Red Earth (company) | 17.2 | 0 | 1 |
| Loghman Pharmaceuticals | 17.2 | 0 | 1 |
| Me, Myself & I | 17.2 | 0 | 1 |
| More | 17.2 | 0 | 1 |
| Naterra | 17.2 | 0 | 1 |
| Natural Ingredients | 17.2 | 0 | 1 |
| Natural skin care | 17.2 | 0 | 1 |
| Notholaenic acid | 17.2 | 0 | 1 |
| nucleobase cation symporter-2 | 17.2 | 0 | 1 |
| Category:Vitamin C | 17.2 | 0 | 1 |
| Sensitive Skin | 17.2 | 0 | 1 |
| Sensitive Skin Magazine | 17.2 | 0 | 1 |
| Sensitive skin | 17.2 | 0 | 1 |
| Sensitive skin | 17.2 | 0 | 1 |
| Sensitive skin type | 17.2 | 0 | 1 |
| Category:Skin care | 17.2 | 0 | 1 |
| Simple Skincare | 17.2 | 0 | 1 |
| simple face mask | 17.2 | 0 | 1 |
| Skin cream | 17.2 | 0 | 1 |
| Smile | 17.2 | 0 | 1 |
| The Itch | 17.2 | 0 | 1 |
| trolamine salicylate | 17.2 | 0 | 1 |
| Vitamin C | 17.2 | 0 | 1 |
| Vitamin C | 17.2 | 0 | 1 |
| Vitamin C and the Common Cold | 17.2 | 0 | 1 |
| Vitamin C discography | 17.2 | 0 | 1 |
| Vitamin C and the common cold | 17.2 | 0 | 1 |
| Vitamin C megadosage | 17.2 | 0 | 1 |
| Category:Songs written by Vitamin C (singer) | 17.2 | 0 | 1 |
| Category:Vitamin C (singer) albums | 17.2 | 0 | 1 |
| Category:Vitamin C (singer) songs | 17.2 | 0 | 1 |
| personal hygiene | 17.2 | 0 | 1 |
| Category:Body care | 17.2 | 0 | 1 |
| surgical mask | 17.2 | 0 | 1 |
| Darou Pakhsh | 17.2 | 0 | 1 |
| OXY | 17.2 | 0 | 1 |
| Date face mask | 17.2 | 0 | 1 |
| Vitamin C derivatives | 17.2 | 0 | 1 |
| Hada Labo | 17.2 | 0 | 1 |
| Cidesco | 17.2 | 0 | 1 |
| viscosupplementation | 17.2 | 0 | 1 |
| baby oil | 17.2 | 0 | 1 |
| Melem | 17.2 | 0 | 1 |
| cream | 17.2 | 0 | 1 |
| Jaber Ebne Hayyan Pharmaceutical Company | 17.2 | 0 | 1 |
| Mannings | 17.2 | 0 | 1 |
| cellular response to L-ascorbic acid | 17.2 | 0 | 1 |
| glycolate metabolic process | 17.2 | 0 | 1 |
| hyaluronic acid binding | 17.2 | 0 | 1 |
| glycosaminoglycan metabolic process | 17.2 | 0 | 1 |
| hyaluronan metabolic process | 17.2 | 0 | 1 |
| hyaluronan catabolic process | 17.2 | 0 | 1 |
| establishment of skin barrier | 17.2 | 0 | 1 |
| L-ascorbic acid metabolic process | 17.2 | 0 | 1 |
| dehydroascorbic acid transport | 17.2 | 0 | 1 |
| response to L-ascorbic acid | 17.2 | 0 | 1 |
| L-ascorbic acid binding | 17.2 | 0 | 1 |
| hyaluronan biosynthetic process | 17.2 | 0 | 1 |
| Pechoin | 17.2 | 0 | 1 |
| Face Cream | 17.2 | 0 | 1 |
| Beauty Brands | 17.2 | 0 | 1 |
| KORA Organics | 17.2 | 0 | 1 |
| Premier Dead Sea | 17.2 | 0 | 1 |
| Nardo's Natural | 17.2 | 0 | 1 |
| Rachel K | 17.2 | 0 | 1 |
| Mano people | 17.2 | 0 | 1 |
| Sensitive Skin | 17.2 | 0 | 1 |
| sodium glycolate | 17.2 | 0 | 1 |
| Q17478340 | 17.2 | 0 | 1 |
| Vitamin C can help prevent cancer say the National Institutes of Health | 17.2 | 0 | 1 |
| Johnson's Baby | 17.2 | 0 | 1 |
| Habp4 | 17.2 | 0 | 1 |
| Habp2 | 17.2 | 0 | 1 |
| Gm7770 | 17.2 | 0 | 1 |
| Gm3318 | 17.2 | 0 | 1 |
| ascorbic acid deficiency | 17.2 | 0 | 1 |
| Fullbeauty Brands | 17.2 | 0 | 1 |
| My Beauty Diary | 17.2 | 0 | 1 |
| Zoe Foster Blake | 17.2 | 0 | 1 |
| Template:Vitamin C | 17.2 | 0 | 1 |
| Skin care | 17.2 | 0 | 1 |
| PAX3 expression in normal skin melanocytes and melanocytic lesions (naevi and melanomas) | 17.2 | 0 | 1 |
| Vitamin C for preventing and treating the common cold | 17.2 | 0 | 1 |
| glyoxalase (glycolic acid-forming) activity | 17.2 | 0 | 1 |
| glycolate biosynthetic process | 17.2 | 0 | 1 |
| L-ascorbic acid transmembrane transporter activity | 17.2 | 0 | 1 |
| Solute carrier family 23 member 1 | 17.2 | 0 | 1 |
| Hyaluronan binding protein 2 | 17.2 | 0 | 1 |
| epidermal lamellar body | 17.2 | 0 | 1 |
| L-ascorbic acid biosynthetic process | 17.2 | 0 | 1 |
| Lymphatic vessel endothelial hyaluronan receptor 1 | 17.2 | 0 | 1 |
| Solute carrier family 23 member 3 | 17.2 | 0 | 1 |
| Solute carrier family 23 member 2 | 17.2 | 0 | 1 |
| Stabilin 2 | 17.2 | 0 | 1 |
| Synthetic plant defense elicitors | 17.2 | 0 | 1 |
| Strategies to increase vitamin C in plants: from plant defense perspective to food biofortification | 17.2 | 0 | 1 |
| glycolate catabolic process | 17.2 | 0 | 1 |
| Hyaluronan synthase 1 | 17.2 | 0 | 1 |
| Hyaluronan synthase 2 | 17.2 | 0 | 1 |
| Hyaluronan mediated motility receptor | 17.2 | 0 | 1 |
| Cauliflower mosaic virus protein P6 inhibits signaling responses to salicylic acid and regulates innate immunity | 17.2 | 0 | 1 |
| Recent loss of vitamin C biosynthesis ability in bats | 17.2 | 0 | 1 |
| Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effects | 17.2 | 0 | 1 |
| Hyaluronan synthase 3 | 17.2 | 0 | 1 |
| Vitamin C in human health and disease is still a mystery? An overview | 17.2 | 0 | 1 |
| Co-synergism of endophyte Penicillium resedanum LK6 with salicylic acid helped Capsicum annuumin biomass recovery and osmotic stress mitigation | 17.2 | 0 | 1 |
| induced systemic resistance | 17.2 | 0 | 1 |
| response to salicylic acid | 17.2 | 0 | 1 |
| Lymphatic vessel endothelial hyaluronan receptor 1 | 17.2 | 0 | 1 |
| Hyaluronic acid binding protein 2 | 17.2 | 0 | 1 |
| Hyaluronic acid binding protein 4 | 17.2 | 0 | 1 |
| Polymorphisms in the estrogen receptor 1 and vitamin C and matrix metalloproteinase gene families are associated with susceptibility to lymphoma | 17.2 | 0 | 1 |
| salicylic acid biosynthetic process | 17.2 | 0 | 1 |
| Hyaluronan mediated motility receptor (RHAMM) | 17.2 | 0 | 1 |
| Hyaluronan synthase 3 | 17.2 | 0 | 1 |
| Hyaluronan synthase 2 | 17.2 | 0 | 1 |
| Hyaluronan synthase 1 | 17.2 | 0 | 1 |
| Solute carrier family 23 (nucleobase transporters), member 3 | 17.2 | 0 | 1 |
| Solute carrier family 23 (nucleobase transporters), member 2 | 17.2 | 0 | 1 |
| Solute carrier family 23 (nucleobase transporters), member 1 | 17.2 | 0 | 1 |
| Human placental sodium-dependent vitamin C transporter (SVCT2): molecular cloning and transport function | 17.2 | 0 | 1 |
| Cloning and functional characterization of the human sodium-dependent vitamin C transporters hSVCT1 and hSVCT2 | 17.2 | 0 | 1 |
| Human vitamin C (L-ascorbic acid) transporter SVCT1 | 17.2 | 0 | 1 |
| Vitamin C and Vitamin E for Alzheimer's Disease | 17.2 | 0 | 1 |
| The Possible Role of Antioxidant Vitamin C in Alzheimer’s Disease Treatment and Prevention | 17.2 | 0 | 1 |
| Induction of interactions between CD44 and hyaluronic acid by a short exposure of human T cells to diverse pro-inflammatory mediators | 17.2 | 0 | 1 |
| detection of salicylic acid stimulus | 17.2 | 0 | 1 |
| cellular response to salicylic acid stimulus | 17.2 | 0 | 1 |
| regulation of salicylic acid mediated signaling pathway | 17.2 | 0 | 1 |
| modulation by symbiont of host salicylic acid-mediated defense response | 17.2 | 0 | 1 |
| positive regulation of systemic acquired resistance | 17.2 | 0 | 1 |
| positive regulation by symbiont of host salicylic acid-mediated defense response | 17.2 | 0 | 1 |
| modulation by symbiont of defense-related host salicylic acid-mediated signal transduction pathway | 17.2 | 0 | 1 |
| induction by symbiont of defense-related host salicylic acid-mediated signal transduction pathway | 17.2 | 0 | 1 |
| suppression by symbiont of defense-related host salicylic acid-mediated signal transduction pathway | 17.2 | 0 | 1 |
| induction by symbiont of host induced systemic resistance | 17.2 | 0 | 1 |
| induction by symbiont of host systemic acquired resistance | 17.2 | 0 | 1 |
| modulation by symbiont of host systemic acquired resistance | 17.2 | 0 | 1 |
| L-ascorbic acid catabolic process | 17.2 | 0 | 1 |
| salicylic acid metabolic process | 17.2 | 0 | 1 |
| salicylic acid catabolic process | 17.2 | 0 | 1 |
| 1,3-dichloropropene metabolic process | 17.2 | 0 | 1 |
| glycolate transmembrane transport | 17.2 | 0 | 1 |
| L-ascorbic acid transmembrane transport | 17.2 | 0 | 1 |
| regulation of L-ascorbic acid biosynthetic process | 17.2 | 0 | 1 |
| negative regulation of L-ascorbic acid biosynthetic process | 17.2 | 0 | 1 |
| positive regulation of salicylic acid mediated signaling pathway | 17.2 | 0 | 1 |
| Face mask use and control of respiratory virus transmission in households | 17.2 | 0 | 1 |
| regulation of salicylic acid metabolic process | 17.2 | 0 | 1 |
| regulation of salicylic acid biosynthetic process | 17.2 | 0 | 1 |
| salicylic acid mediated signaling pathway | 17.2 | 0 | 1 |
| systemic acquired resistance, salicylic acid mediated signaling pathway | 17.2 | 0 | 1 |
| modulation by symbiont of salicylic acid levels in host | 17.2 | 0 | 1 |
| negative regulation by symbiont of salicylic acid levels in host | 17.2 | 0 | 1 |
| salicylic acid binding | 17.2 | 0 | 1 |
| glycolate dehydrogenase activity | 17.2 | 0 | 1 |
| methyl salicylate esterase activity | 17.2 | 0 | 1 |
| salicylic acid glucosyltransferase (glucoside-forming) activity | 17.2 | 0 | 1 |
| salicylic acid glucosyltransferase (ester-forming) activity | 17.2 | 0 | 1 |
| glycolate transmembrane transporter activity | 17.2 | 0 | 1 |
| xanthine/uracil/vitamin C permease EAE_08570 | 17.2 | 0 | 1 |
| xanthine/uracil/vitamin C permease ECL_03999 | 17.2 | 0 | 1 |
| putative xanthine/uracil/vitamin C permease KPHS_36160 | 17.2 | 0 | 1 |
| xanthine/uracil/vitamin C permease Psyr_4286 | 17.2 | 0 | 1 |
| xanthine/uracil/vitamin C permease L171588 | 17.2 | 0 | 1 |
| xanthine/uracil/vitamin C permease Moth_1232 | 17.2 | 0 | 1 |
| xanthine/uracil/vitamin C permease LSEI_0151 | 17.2 | 0 | 1 |
| Kaya Limited | 17.2 | 0 | 1 |
| xanthine/uracil/vitamin C permease NGR_b12650 | 17.2 | 0 | 1 |
| xanthine/uracil/vitamin C permease Smed_3842 | 17.2 | 0 | 1 |
| xanthine/uracil/vitamin C permease Smed_5276 | 17.2 | 0 | 1 |
| xanthine/uracil/vitamin C permease Smed_4615 | 17.2 | 0 | 1 |
| Xanthine/uracil/vitamin C permease L171588 | 17.2 | 0 | 1 |
| Xanthine/uracil/vitamin C permease Moth_1232 | 17.2 | 0 | 1 |
| Putative xanthine/uracil/vitamin C permease family protein MAB_3353c | 17.2 | 0 | 1 |
| Xanthine/uracil/vitamin C permease Smed_3842 | 17.2 | 0 | 1 |
| Xanthine/uracil/vitamin C permease Smed_5276 | 17.2 | 0 | 1 |
| Xanthine/uracil/vitamin C permease Smed_4615 | 17.2 | 0 | 1 |
| Aveeno Baby product line | 17.2 | 0 | 1 |
| EOS Products, LLC | 17.2 | 0 | 1 |
| Developmental toxicity interactions of salicylic acid and radiofrequency radiation or 2-methoxyethanol in rats | 17.2 | 0 | 1 |
| Hyaluronic acid binding ability of human sperm reflects cellular maturity and fertilizing potential: selection of sperm for intracytoplasmic sperm injection | 17.2 | 0 | 1 |
| The pattern of tyrosine phosphorylation in human sperm in response to binding to zona pellucida or hyaluronic acid | 17.2 | 0 | 1 |
| Thermal sensation of the body as influenced by the thermal microclimate in a face mask | 17.2 | 0 | 1 |
| Liposomal vitamin c | 17.2 | 0 | 1 |
| Xanthine/uracil/vitamin C permease Psyr_4286 | 17.2 | 0 | 1 |
| Xanthine/uracil/vitamin C permease NGR_b12650 | 17.2 | 0 | 1 |
| Xanthine/uracil/vitamin C permease EAE_08570 | 17.2 | 0 | 1 |
| Xanthine/uracil/vitamin C permease ECL_03999 | 17.2 | 0 | 1 |
| Hyaluronic acid binding by human sperm indicates cellular maturity, viability, and unreacted acrosomal status. | 17.2 | 0 | 1 |
| Putative xanthine/uracil/vitamin C permease family protein MAB_3353c | 17.2 | 0 | 1 |
| Hyaluronic acid and other conservative treatment options for osteoarthritis of the ankle | 17.2 | 0 | 1 |
| Vitamin C for treating atrial fibrillation | 17.2 | 0 | 1 |
| Vitamin C supplementation in pregnancy | 17.2 | 0 | 1 |
| Vitamin C for preventing complex regional pain syndrome (type I) after wrist fractures in adults | 17.2 | 0 | 1 |
| Topical azelaic acid, salicylic acid, nicotinamide, and sulphur for acne | 17.2 | 0 | 1 |
| Vitamin C supplementation for the primary prevention of cardiovascular disease | 17.2 | 0 | 1 |
| Topical oils for the prevention or treatment of dry skin in term infants | 17.2 | 0 | 1 |
| Vitamin C supplementation for asthma | 17.2 | 0 | 1 |
| Vitamin C and E for asthma and exercise-induced bronchoconstriction | 17.2 | 0 | 1 |
| Vitamin C for preventing and treating pneumonia | 17.2 | 0 | 1 |
| Skin-to-skin care for procedural pain in neonates | 17.2 | 0 | 1 |
| Vitamin C for asthma and exercise induced bronchoconstriction | 17.2 | 0 | 1 |
| Vitamin C for preventing and treating the common cold | 17.2 | 0 | 1 |
| Vitamin C for preventing and treating tetanus | 17.2 | 0 | 1 |
| Vitamin C for asthma and exercise-induced bronchoconstriction | 17.2 | 0 | 1 |
| Skin-to-skin care for procedural pain in neonates | 17.2 | 0 | 1 |
| Vitamin C for preventing complex regional pain syndrome (type I) after wrist fractures in adults | 17.2 | 0 | 1 |
| Vitamin C supplementation for asthma | 17.2 | 0 | 1 |
| Chlorhexidine skin care for the prevention of infection in term neonates | 17.2 | 0 | 1 |
| Hyaluronic Acid inclusion in embryo transfer media for assisted reproductive technologies | 17.2 | 0 | 1 |
| Vitamin C and superoxide dismutase (SOD) for diabetic retinopathy | 17.2 | 0 | 1 |
| Vitamin C for preventing and treating tetanus | 17.2 | 0 | 1 |
| Vitamin C for preventing and treating pneumonia | 17.2 | 0 | 1 |
| Vitamin C for preventing and treating the common cold | 17.2 | 0 | 1 |
| Vitamin C and superoxide dismutase (SOD) for diabetic retinopathy | 17.2 | 0 | 1 |
| Vitamin C for preventing and treating tetanus | 17.2 | 0 | 1 |
| Vitamin C supplementation in pregnancy | 17.2 | 0 | 1 |
| Vitamin C for preventing and treating the common cold | 17.2 | 0 | 1 |
| Vitamin C for preventing and treating pneumonia | 17.2 | 0 | 1 |
| Endotracheal intubation versus face mask for newborns resuscitated with positive pressure ventilation at birth | 17.2 | 0 | 1 |
| Vitamin C supplementation for asthma | 17.2 | 0 | 1 |
| Vitamin C supplementation in pregnancy | 17.2 | 0 | 1 |
| Putative xanthine/uracil/vitamin C permease KPHS_36160 | 17.2 | 0 | 1 |
| Phosphatidylinositol 4-kinase activation is an early response to salicylic acid in Arabidopsis suspension cells | 17.2 | 0 | 1 |
| Decreased expression of the vitamin C transporter SVCT1 by ascorbic acid in a human intestinal epithelial cell line | 17.2 | 0 | 1 |
| Loss of corneodesmosin leads to severe skin barrier defect, pruritus, and atopy: unraveling the peeling skin disease | 17.2 | 0 | 1 |
| Elastase 2 is expressed in human and mouse epidermis and impairs skin barrier function in Netherton syndrome through filaggrin and lipid misprocessing | 17.2 | 0 | 1 |
| Lipoxygenases mediate the effect of essential fatty acid in skin barrier formation: a proposed role in releasing omega-hydroxyceramide for construction of the corneocyte lipid envelope | 17.2 | 0 | 1 |
| Transport model of the human Na+-coupled L-ascorbic acid (vitamin C) transporter SVCT1 | 17.2 | 0 | 1 |
| Polarized localization of vitamin C transporters, SVCT1 and SVCT2, in epithelial cells | 17.2 | 0 | 1 |
| TRP channel regulates EGFR signaling in hair morphogenesis and skin barrier formation | 17.2 | 0 | 1 |
| Functional role of conserved transmembrane segment 1 residues in human sodium-dependent vitamin C transporters | 17.2 | 0 | 1 |
| Hierarchal contribution of N- and C-terminal sequences to the differential localization of homologous sodium-dependent vitamin C transporters, SVCT1 and SVCT2, in epithelial cells | 17.2 | 0 | 1 |
| Molecular cloning of human fibroblast hyaluronic acid-binding protein confirms its identity with P-32, a protein co-purified with splicing factor SF2. Hyaluronic acid-binding protein as P-32 protein, co-purified with splicing factor SF2 | 17.2 | 0 | 1 |
| Psoriasin binds calcium and is upregulated by calcium to levels that resemble those observed in normal skin | 17.2 | 0 | 1 |
| Activity of a sodium-dependent vitamin C transporter (SVCT) in MDCK-MDR1 cells and mechanism of ascorbate uptake | 17.2 | 0 | 1 |
| The expression of epidermal lipoxygenases and transglutaminase-1 is perturbed by NIPAL4 mutations: indications of a common metabolic pathway essential for skin barrier homeostasis | 17.2 | 0 | 1 |
| CD44-dependent intracellular and extracellular catabolism of hyaluronic acid by hyaluronidase-1 and -2 | 17.2 | 0 | 1 |
| RGD1565367 | 17.2 | 0 | 1 |
| Hyaluronic acid in human articular cartilage. Age-related changes in content and size | 17.2 | 0 | 1 |
| Down regulation of virulence factors of Pseudomonas aeruginosa by salicylic acid attenuates its virulence on Arabidopsis thaliana and Caenorhabditis elegans | 17.2 | 0 | 1 |
| The efficiency of tools used to retract a football helmet face mask | 17.2 | 0 | 1 |
| The chemical nature of vitamin C | 17.2 | 0 | 1 |
| Hydration-driven transport of deformable lipid vesicles through fine pores and the skin barrier | 17.2 | 0 | 1 |
| A coarse-grained molecular model for glycosaminoglycans: application to chondroitin, chondroitin sulfate, and hyaluronic acid. | 17.2 | 0 | 1 |
| Studies in fetal wound healing. V. A prolonged presence of hyaluronic acid characterizes fetal wound fluid | 17.2 | 0 | 1 |
| High-dose vitamin C therapy: renewed hope or false promise? | 17.2 | 0 | 1 |
| Intravenously administered vitamin C as cancer therapy: three cases | 17.2 | 0 | 1 |
| Salicylic acid-independent ENHANCED DISEASE SUSCEPTIBILITY1 signaling in Arabidopsis immunity and cell death is regulated by the monooxygenase FMO1 and the Nudix hydrolase NUDT7 | 17.2 | 0 | 1 |
| Vitamin C deficiency and depletion in the United States: the Third National Health and Nutrition Examination Survey, 1988 to 1994 | 17.2 | 0 | 1 |
| Experimental and clinical results with proximal end-to-end duodenojejunostomy for pathologic duodenogastric reflux | 17.2 | 0 | 1 |
| Dehydroascorbic acid, a blood-brain barrier transportable form of vitamin C, mediates potent cerebroprotection in experimental stroke | 17.2 | 0 | 1 |
| Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci | 17.2 | 0 | 1 |
| Hyaluronic acid capsule and the role of streptococcal entry into keratinocytes in invasive skin infection | 17.2 | 0 | 1 |
| Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance | 17.2 | 0 | 1 |
| A human sodium-dependent vitamin C transporter 2 isoform acts as a dominant-negative inhibitor of ascorbic acid transport | 17.2 | 0 | 1 |
| Vitamin C may alleviate exercise-induced bronchoconstriction: a meta-analysis | 17.2 | 0 | 1 |
| Randomized, controlled trial evaluating a baby wash product on skin barrier function in healthy, term neonates | 17.2 | 0 | 1 |
| Vitamin C Intake, Circulating Vitamin C and Risk of Stroke: A Meta‐Analysis of Prospective Studies | 17.2 | 0 | 1 |
| Population-Based Inorganic Mercury Biomonitoring and the Identification of Skin Care Products as a Source of Exposure in New York City | 17.2 | 0 | 1 |
| The genetics of vitamin C loss in vertebrates | 17.2 | 0 | 1 |
| Vitamin C controls the cystic fibrosis transmembrane conductance regulator chloride channel | 17.2 | 0 | 1 |
| A Critical Review of Vitamin C for the Prevention of Age-Related Cognitive Decline and Alzheimer's Disease | 17.2 | 0 | 1 |
| Cytokinins mediate resistance against Pseudomonas syringae in tobacco through increased antimicrobial phytoalexin synthesis independent of salicylic acid signaling | 17.2 | 0 | 1 |
| Long-term use of supplemental multivitamins, vitamin C, vitamin E, and folate does not reduce the risk of lung cancer | 17.2 | 0 | 1 |
| Retinal pathology and skin barrier defect in mice carrying a Stargardt disease-3 mutation in elongase of very long chain fatty acids-4 | 17.2 | 0 | 1 |
| Interrelation of vitamin C, infection, haemostatic factors, and cardiovascular disease | 17.2 | 0 | 1 |
| Changes of terminal cancer patients' health-related quality of life after high dose vitamin C administration | 17.2 | 0 | 1 |
| Vitamin C intake and the risk of gout in men: a prospective study | 17.2 | 0 | 1 |
| Vitamin C: update on physiology and pharmacology | 17.2 | 0 | 1 |
| Use of hyaluronic acid fillers for the treatment of the aging face | 17.2 | 0 | 1 |
| Tropic Skin Care | 17.2 | 0 | 1 |
| Use of Dinitrophenol in Nutritional Disorders : A Critical Survey of Clinical Results | 17.2 | 0 | 1 |
| Antioxidants vitamin C and vitamin e for the prevention and treatment of cancer | 17.2 | 0 | 1 |
| Maturational loss of the vitamin C transporter in erythrocytes | 17.2 | 0 | 1 |
| Identification of hyaluronic acid binding sites in the extracellular domain of CD44 | 17.2 | 0 | 1 |
| Salicylic acid and NPR1 induce the recruitment of trans-activating TGA factors to a defense gene promoter in Arabidopsis | 17.2 | 0 | 1 |
| A Randomized Controlled Trial of Acetyl Salicyclic Acid in the Secondary Prevention of Mortality from Myocardial Infarction | 17.2 | 0 | 1 |
| Reduction of 1-Cys peroxiredoxins by ascorbate changes the thiol-specific antioxidant paradigm, revealing another function of vitamin C | 17.2 | 0 | 1 |
| THE HYDROLYSIS OF HYALURONIC ACID BY BACTERIAL ENZYMES | 17.2 | 0 | 1 |
| A FURTHER CONTRIBUTION TO VITAMIN C THERAPY IN EXPERIMENTAL POLIOMYELITIS | 17.2 | 0 | 1 |
| VITAMIN C IN RELATION TO EXPERIMENTAL POLIOMYELITIS : WITH INCIDENTAL OBSERVATIONS ON CERTAIN MANIFESTATIONS IN MACACUS RHESUS MONKEYS ON A SCORBUTIC DIET | 17.2 | 0 | 1 |
| VITAMIN C THERAPY AND PROPHYLAXIS IN EXPERIMENTAL POLIOMYELITIS | 17.2 | 0 | 1 |
| INACTIVATION OF POLIOMYELITIS VIRUS IN VITRO BY CRYSTALLINE VITAMIN C (ASCORBIC ACID) | 17.2 | 0 | 1 |
| Fertility testing and ICSI sperm selection by hyaluronic acid binding: clinical and genetic aspects | 17.2 | 0 | 1 |
| Intracellular hyaluronic acid binding protein | 17.2 | 0 | 1 |
| The enhancement of the hyperglycemic effect of S-nitrosoglutathione and S-nitroso-N-acetylpenicillamine by vitamin C in an animal model | 17.2 | 0 | 1 |
| Vitamin C and vitamin E in prevention of Nonalcoholic Fatty Liver Disease (NAFLD) in choline deficient diet fed rats | 17.2 | 0 | 1 |
| Topically applied vitamin C increases the density of dermal papillae in aged human skin | 17.2 | 0 | 1 |
| Impact on the quality of life of lymphoedema patients following introduction of a hygiene and skin care regimen in a Guyanese community endemic for lymphatic filariasis: A preliminary clinical intervention study | 17.2 | 0 | 1 |
| The effect on endothelial function of vitamin C during methionine induced hyperhomocysteinaemia | 17.2 | 0 | 1 |
| Cumulus expansion, nuclear maturation and connexin 43, cyclooxygenase-2 and FSH receptor mRNA expression in equine cumulus-oocyte complexes cultured in vitro in the presence of FSH and precursors for hyaluronic acid synthesis | 17.2 | 0 | 1 |
| Inhibition of antithrombin by hyaluronic acid may be involved in the pathogenesis of rheumatoid arthritis | 17.2 | 0 | 1 |
| Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action | 17.2 | 0 | 1 |
| The ugly side of beauty products | 17.2 | 0 | 1 |
| Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus | 17.2 | 0 | 1 |
| Misleading information on the properties of vitamin C | 17.2 | 0 | 1 |
| Narrow scope of vitamin C review | 17.2 | 0 | 1 |
| Toxicity tests: "inert" and active ingredients | 17.2 | 0 | 1 |
| Intra-articular injections of high-molecular-weight hyaluronic acid have biphasic effects on joint inflammation and destruction in rat antigen-induced arthritis | 17.2 | 0 | 1 |
| Lubriderm | 17.2 | 0 | 1 |
| Vitamin C inhibits benzo[a]pyrene-induced cell cycle changes partly via cyclin D1/E2F pathway in human embryo lung fibroblasts | 17.2 | 0 | 1 |
| Cleanser-induced effects on skin barrier function | 17.2 | 0 | 1 |
| Effect of dietary vitamin C on guinea pig pulmonary response to inhalation of cotton dust | 17.2 | 0 | 1 |
| Inhibition of cyclophosphamide and mitomycin c-induced sister chromatid exchanges in mice by vitamin c | 17.2 | 0 | 1 |
| Vitamin C for treating atrial fibrillation | 17.2 | 0 | 1 |
| Dressings and topical agents containing hyaluronic acid for chronic wound healing | 17.2 | 0 | 1 |
| Vitamin C and Heart Health: A Review Based on Findings from Epidemiologic Studies | 17.2 | 0 | 1 |
| Meeting the Challenges of Acne Treatment in Asian Patients: A Review of the Role of Dermocosmetics as Adjunctive Therapy | 17.2 | 0 | 1 |
| Neuropharmacological efficacy of the traditional Japanese Kampo medicine yokukansan and its active ingredients | 17.2 | 0 | 1 |
| Genetic basis for hyper production of hyaluronic acid in natural and engineered microorganisms | 17.2 | 0 | 1 |
| Multiple Targets of Salicylic Acid and Its Derivatives in Plants and Animals | 17.2 | 0 | 1 |
| Hyaluronic acid as a biomarker of fibrosis in chronic liver diseases of different etiologies | 17.2 | 0 | 1 |
| Clinical evidence in the treatment of rotator cuff tears with hyaluronic acid | 17.2 | 0 | 1 |
| Hyaluronic acid and tendon lesions | 17.2 | 0 | 1 |
| Vitamin C in Health and Disease: Its Role in the Metabolism of Cells and Redox State in the Brain | 17.2 | 0 | 1 |
| Delayed-type Necrosis after Soft-tissue Augmentation with Hyaluronic Acid | 17.2 | 0 | 1 |
| Dual action of vitamin C versus degradation and supplementation | 17.2 | 0 | 1 |
| 60 YEARS OF POMC: From POMC and α-MSH to PAM, molecular oxygen, copper, and vitamin C | 17.2 | 0 | 1 |
| The mechanism of action for hyaluronic acid treatment in the osteoarthritic knee: a systematic review | 17.2 | 0 | 1 |
| Microspectroscopic Confocal Raman and Macroscopic Biophysical Measurements in the in vivo Assessment of the Skin Barrier: Perspective for Dermatology and Cosmetic Sciences | 17.2 | 0 | 1 |
| Salicylic acid as a peeling agent: a comprehensive review | 17.2 | 0 | 1 |
| Glans Penis Augmentation Using Hyaluronic Acid Gel as an Injectable Filler | 17.2 | 0 | 1 |
| Histamine and Skin Barrier: Are Histamine Antagonists Useful for the Prevention or Treatment of Atopic Dermatitis? | 17.2 | 0 | 1 |
| Salicylic acid-induced abiotic stress tolerance and underlying mechanisms in plants | 17.2 | 0 | 1 |
| Heparin in malignant glioma: review of preclinical studies and clinical results | 17.2 | 0 | 1 |
| Molecular characterizations of glioblastoma, targeted therapy, and clinical results to date | 17.2 | 0 | 1 |
| Optical coherence tomography (OCT) of collagen in normal skin and skin fibrosis | 17.2 | 0 | 1 |
| Skin care: Historical and contemporary views | 17.2 | 0 | 1 |
| Mechanisms of abnormal lamellar body secretion and the dysfunctional skin barrier in patients with atopic dermatitis | 17.2 | 0 | 1 |
| Glycolic acid peel therapy – a current review | 17.2 | 0 | 1 |
| Assessment of clinical practice guideline methodology for the treatment of knee osteoarthritis with intra-articular hyaluronic acid | 17.2 | 0 | 1 |
| Metabolic Correction in the Management of Diabetic Peripheral Neuropathy: Improving Clinical Results Beyond Symptom Control | 17.2 | 0 | 1 |
| Systematic Review for Effectiveness of Hyaluronic Acid in the Treatment of Severe Degenerative Joint Disease (DJD) of the Knee | 17.2 | 0 | 1 |
| State-of-the-Art management of knee osteoarthritis | 17.2 | 0 | 1 |
| Coacervate delivery systems for proteins and small molecule drugs | 17.2 | 0 | 1 |
| Managing knee ostheoarthritis: efficacy of hyaluronic acid injections | 17.2 | 0 | 1 |
| Cytokinin cross-talking during biotic and abiotic stress responses | 17.2 | 0 | 1 |
| Biodegradable polymer Biolimus-eluting stent (Nobori®) for the treatment of coronary artery lesions: review of concept and clinical results | 17.2 | 0 | 1 |
| Hyaluronic Acid and Wound Healing | 17.2 | 0 | 1 |
| Hyaluronic acid hydrogels for vocal fold wound healing | 17.2 | 0 | 1 |
| Effects of vitamin C supplementation on blood pressure: a meta-analysis of randomized controlled trials | 17.2 | 0 | 1 |
| The effects of intravesical therapy with hyaluronic acid for painful bladder syndrome: Preliminary Chinese experience and systematic review | 17.2 | 0 | 1 |
| Regulation of vitamin C homeostasis during deficiency | 17.2 | 0 | 1 |
| Vitamin C, Gastritis, and Gastric Disease: A Historical Review and Update | 17.2 | 0 | 1 |
| The role of skin care as an integral component in the management of acne vulgaris: part 1: the importance of cleanser and moisturizer ingredients, design, and product selection | 17.2 | 0 | 1 |
| Regulation of the Epigenome by Vitamin C | 17.2 | 0 | 1 |
| Antioxidants in Athlete’s Basic Nutrition: Considerations towards a Guideline for the Intake of Vitamin C and Vitamin E | 17.2 | 0 | 1 |
| Signalling crosstalk in light stress and immune reactions in plants | 17.2 | 0 | 1 |
| Drug Reaction, Skin Care, Skin Loss | 17.2 | 0 | 1 |
| Hyaluronic Acid: from biochemical characteristics to its clinical translation in assessment of liver fibrosis | 17.2 | 0 | 1 |
| AHL-priming functions via oxylipin and salicylic acid | 17.2 | 0 | 1 |
| Acne Treatment Based on Selective Photothermolysis of Sebaceous Follicles with Topically Delivered Light-Absorbing Gold Microparticles | 17.2 | 0 | 1 |
| Clinical Results of Hypomethylating Agents in AML Treatment | 17.2 | 0 | 1 |
| Incorporation of a barrier protection cream in the management of chronic hand dermatitis: focus on data supporting an established hand protectant formulation and modifications designed to assist in barrier repair | 17.2 | 0 | 1 |
| Epidermal Permeability Barrier Defects and Barrier Repair Therapy in Atopic Dermatitis | 17.2 | 0 | 1 |
| Human Genetic Variation Influences Vitamin C Homeostasis by Altering Vitamin C Transport and Antioxidant Enzyme Function | 17.2 | 0 | 1 |
| Improving adherence to acne treatment: the emerging role of application software | 17.2 | 0 | 1 |
| Evaluation of Vitamin C for Adjuvant Sepsis Therapy | 17.2 | 0 | 1 |
| hyaluronan | 17.2 | 0 | 1 |
| 3,5-dibromo-4-hydroxybenzoic acid | 17.2 | 0 | 1 |
| isopropyl salicylate | 17.2 | 0 | 1 |
| physostigmine salicylate | 17.2 | 0 | 1 |
| (2-naphthyloxy)acetic acid | 17.2 | 0 | 1 |
| 3,5-dichloro-4-hydroxybenzoic acid | 17.2 | 0 | 1 |
| beta-D-GlcpA-(1->3)-beta-D-GlcpNAc-(1->4)-beta-D-GlcpA-(1->3)-D-GlcpNAc | 17.2 | 0 | 1 |
| hydroxy(phenyl)2-thienylacetic acid | 17.2 | 0 | 1 |
| valerylsalicylic acid | 17.2 | 0 | 1 |
| 2-(D-glucosyloxy)benzoic acid | 17.2 | 0 | 1 |
| amyl salicylate | 17.2 | 0 | 1 |
| trans-3-Hexenyl salicylate | 17.2 | 0 | 1 |
| 2-Ethylhexyl salicylate | 17.2 | 0 | 1 |
| cis-3-Hexenyl salicylate | 17.2 | 0 | 1 |
| 3-aminosalicylic acid | 17.2 | 0 | 1 |
| salicylic acid monoethanolamine | 17.2 | 0 | 1 |
| dodecylamine salicylate | 17.2 | 0 | 1 |
| eseridine salicylate | 17.2 | 0 | 1 |
| nicotinatesalicylic acid | 17.2 | 0 | 1 |
| bamipine salicylate | 17.2 | 0 | 1 |
| 5,5'-methylenedisalicyclic acid | 17.2 | 0 | 1 |
| carbazochrome salicylate | 17.2 | 0 | 1 |
| mordant yellow 10 | 17.2 | 0 | 1 |
| (E,E)-3,5-di-(4-(2-carboxyethylcarbamoyl)phenylazo)salicylic acid | 17.2 | 0 | 1 |
| 4-chlorosalicylic acid | 17.2 | 0 | 1 |
| oxyquinoline salicylate | 17.2 | 0 | 1 |
| benzydamine salicylate | 17.2 | 0 | 1 |
| 2-propionyloxybenzoic acid | 17.2 | 0 | 1 |
| (E,E)-5-((2-(4-(2-carboxyethylcarbamoyl)phenylazo)-4-(2-carboxyethyl-carbamoyl)(phenylazo(salicylic acid)))) | 17.2 | 0 | 1 |
| (E)-3-(4-(2-carboxyethylcarbamoyl) phenylazo)-salicylic acid | 17.2 | 0 | 1 |
| morpholine salicylate | 17.2 | 0 | 1 |
| (E)-5-((3-(2-carboxyethylcarbamoyl)phenyl)azo(salicylic acid | 17.2 | 0 | 1 |
| methyl salicylate 2-ethylbutyrate | 17.2 | 0 | 1 |
| 3-pyridylmethylamine salicylate | 17.2 | 0 | 1 |
| citrosalic acid | 17.2 | 0 | 1 |
| alizarine yellow R sodium | 17.2 | 0 | 1 |
| 2-hexanoyloxybenzoic acid | 17.2 | 0 | 1 |
| salazosulfadimidine | 17.2 | 0 | 1 |
| Cationic liposome–hyaluronic acid hybrid nanoparticles for intranasal vaccination with subunit antigens | 17.2 | 0 | 1 |
| Porous chitosan scaffolds with embedded hyaluronic acid/chitosan/plasmid-DNA nanoparticles encoding TGF-β1 induce DNA controlled release, transfected chondrocytes, and promoted cell proliferation | 17.2 | 0 | 1 |
| Perpendicular Strut Injection of Hyaluronic Acid Filler for Deep Wrinkles | 17.2 | 0 | 1 |
| Treatment of Mycobacterium tuberculosis-Infected Macrophages with Poly(Lactic-Co-Glycolic Acid) Microparticles Drives NFκB and Autophagy Dependent Bacillary Killing | 17.2 | 0 | 1 |
| Image Statistics and the Fine Lines of Material Perception | 17.2 | 0 | 1 |
| Salicylic acid, a plant defense hormone, is specifically secreted by a molluscan herbivore | 17.2 | 0 | 1 |
| Effect of Noninvasive Ventilation Delivered by Helmet vs Face Mask on the Rate of Endotracheal Intubation in Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial | 17.2 | 0 | 1 |
| Phospholipase D Activation Is an Early Component of the Salicylic Acid Signaling Pathway in Arabidopsis Cell Suspensions | 17.2 | 0 | 1 |
| Mechanism of hyaluronan binding and degradation: structure of Streptococcus pneumoniae hyaluronate lyase in complex with hyaluronic acid disaccharide at 1.7 A resolution | 17.2 | 0 | 1 |
| Vitamin C inhibits the enzymatic activity of Streptococcus pneumoniae hyaluronate lyase | 17.2 | 0 | 1 |
| Hyaluronic acid: molecular conformations and interactions in two sodium salts | 17.2 | 0 | 1 |
| Hyaluronic acid: Structure of a fully extended 3-fold helical sodium salt and comparison with the less extended 4-fold helical forms | 17.2 | 0 | 1 |
| Structural Basis for Substrate Recognition in the Salicylic Acid Carboxyl Methyltransferase Family | 17.2 | 0 | 1 |
| Iodination of salicylic acid improves its binding to transthyretin | 17.2 | 0 | 1 |
| Salicylic Acid Based Small Molecule Inhibitor for the Oncogenic Src Homology-2 Domain Containing Protein Tyrosine Phosphatase-2 (SHP2) | 17.2 | 0 | 1 |
| Salicylic Acid Induces Mitochondrial Injury by Inhibiting Ferrochelatase Heme Biosynthesis Activity | 17.2 | 0 | 1 |
| Antibiotic resistance in acne treatment | 17.2 | 0 | 1 |
| Crystal structure of a phosphorylation-coupled vitamin C transporter | 17.2 | 0 | 1 |
| Hyaluronic acid: The role of divalent cations in conformation and packing | 17.2 | 0 | 1 |
| The importance of an innervated and intact antrum and pylorus in preventing postoperative duodenogastric reflux and gastritis | 17.2 | 0 | 1 |
| diphenhydramine salicylate | 17.2 | 0 | 1 |
| Post Holdings | 17.2 | 0 | 1 |
| Skin barrier in rosacea | 17.2 | 0 | 1 |
| Interventions to increase adherence to acne treatment | 17.2 | 0 | 1 |
| New developments in acne treatment: role of combination adapalene-benzoylperoxide | 17.2 | 0 | 1 |
| Current management of non-palpable testes: a literature review and clinical results | 17.2 | 0 | 1 |
| Hyaluronic acid fillers with cohesive polydensified matrix for soft-tissue augmentation and rejuvenation: a literature review | 17.2 | 0 | 1 |
| From Normal Skin to Squamous Cell Carcinoma: A Quest for Novel Biomarkers | 17.2 | 0 | 1 |
| Intravenous Vitamin C (PDQ®): Health Professional Version | 17.2 | 0 | 1 |
| Inflammasomes and Natural Ingredients towards New Anti-Inflammatory Agents | 17.2 | 0 | 1 |
| Developing food allergy: a potential immunologic pathway linking skin barrier to gut | 17.2 | 0 | 1 |
| Volumetric techniques: three-dimensional midface modeling | 17.2 | 0 | 1 |
| Hyaluronic Acid: Perspectives in Upper Aero-Digestive Tract. A Systematic Review | 17.2 | 0 | 1 |
| Active Ingredients of Treatment and Client Mechanisms of Change in Behavioral Treatments for Alcohol Use Disorders: Progress 10 Years Later | 17.2 | 0 | 1 |
| Cullin-RING ubiquitin ligases in salicylic acid-mediated plant immune signaling | 17.2 | 0 | 1 |
| Effectiveness of hyaluronic acid administration in treating adhesive capsulitis of the shoulder: a systematic review of randomized controlled trials | 17.2 | 0 | 1 |
| Role of Micronutrients in Skin Health and Function | 17.2 | 0 | 1 |
| Anti-tumor activities of active ingredients in Compound Kushen Injection | 17.2 | 0 | 1 |
| Targeting transporters: Promoting blood–brain barrier repair in response to oxidative stress injury | 17.2 | 0 | 1 |
| CD44 interaction with c-Src kinase promotes cortactin-mediated cytoskeleton function and hyaluronic acid-dependent ovarian tumor cell migration | 17.2 | 0 | 1 |
| Human Na(+)-dependent vitamin C transporter 1 (hSVCT1): primary structure, functional characteristics and evidence for a non-functional splice variant | 17.2 | 0 | 1 |
| Noninvasive glucose monitoring: comprehensive clinical results. Cygnus Research Team | 17.2 | 0 | 1 |
| Omeprazole and dietary nitrate independently affect levels of vitamin C and nitrite in gastric juice | 17.2 | 0 | 1 |
| Differences in hyaluronic acid-mediated functions and signaling in arterial, microvessel, and vein-derived human endothelial cells | 17.2 | 0 | 1 |
| Neonatal skin care: the scientific basis for practice | 17.2 | 0 | 1 |
| Cosmetics and skin care products. A historical perspective | 17.2 | 0 | 1 |
| Does vitamin C act as a pro-oxidant under physiological conditions? | 17.2 | 0 | 1 |
| Acetyl salicylic acid improves somatosensory evoked potentials in streptozotocin-diabetic rats | 17.2 | 0 | 1 |
| Acetyl salicylic acid (aspirin), micronutrients and chloroquine in the management of the acquired immunodeficiency syndrome (AIDS) | 17.2 | 0 | 1 |
| Role of salicylic acid in systemic resistance induced by Pseudomonas fluorescens against Fusarium oxysporum f. sp. ciceri in chickpea | 17.2 | 0 | 1 |
| A rapid high-performance liquid chromatographic method for the simultaneous quantitation of aspirin, salicylic acid, and caffeine in effervescent tablets | 17.2 | 0 | 1 |
| Q28166123 | 17.2 | 0 | 1 |
| Gastroprotection by vitamin C--a heme oxygenase-1-dependent mechanism? | 17.2 | 0 | 1 |
| Antioxidant effect of acetylsalicylic and salicylic acid in rat brain slices subjected to hypoxia | 17.2 | 0 | 1 |
| Comparative pharmacokinetics of acetyl salicylic acid and its metabolites in children suffering from autoimmune diseases | 17.2 | 0 | 1 |
| Auditory sensitivity in rats exposed to toluene and/or acetyl salicylic acid | 17.2 | 0 | 1 |
| Antioxidant effects of a single dose of acetylsalicylic acid and salicylic acid in rat brain slices subjected to oxygen-glucose deprivation in relation with its antiplatelet effect | 17.2 | 0 | 1 |
| Pharmacokinetics and metabolic rates of acetyl salicylic acid and its metabolites in an Otomi ethnic group of Mexico | 17.2 | 0 | 1 |
| Cell cycle arrest and modulation of HO-1 expression induced by acetyl salicylic acid in hepatocarcinogenesis | 17.2 | 0 | 1 |
| Inhibition of cardiac mitochondrial respiration by salicylic acid and acetylsalicylate | 17.2 | 0 | 1 |
| Association of thromboxane A2 receptor gene polymorphism with the phenotype of acetyl salicylic acid-intolerant asthma | 17.2 | 0 | 1 |
| Flow-through UV spectrophotometric sensor for determination of (acetyl)salicylic acid in pharmaceutical preparations | 17.2 | 0 | 1 |
| Serum vitamin C concentration is low in peripheral arterial disease and is associated with inflammation and severity of atherosclerosis | 17.2 | 0 | 1 |
| Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: the St. Francis Heart Study randomized clinical trial | 17.2 | 0 | 1 |
| Preparation and some properties of crystalline glycolic acid oxidase of spinach | 17.2 | 0 | 1 |
| Role of reactive oxygen metabolites in aspirin-induced gastric damage in humans: gastroprotection by vitamin C | 17.2 | 0 | 1 |
| Acetylsalicylic acid and vitamin C | 17.2 | 0 | 1 |
| Salicylic acid modulates oxidative stress and glutathione peroxidase activity in the rat colon | 17.2 | 0 | 1 |
| Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors | 17.2 | 0 | 1 |
| Salicylic acid in the serum of subjects not taking aspirin. Comparison of salicylic acid concentrations in the serum of vegetarians, non-vegetarians, and patients taking low dose aspirin | 17.2 | 0 | 1 |
| Comparison of nitric oxide-releasing NSAID and vitamin C with classic NSAID in healing of chronic gastric ulcers; involvement of reactive oxygen species | 17.2 | 0 | 1 |
| Hand hygiene and skin health | 17.2 | 0 | 1 |
| Review of the clinical results of arthroscopic meniscal repair | 17.2 | 0 | 1 |
| Salicylic acid: a link between aspirin, diet and the prevention of colorectal cancer | 17.2 | 0 | 1 |
| Characterization of the genomic structure of the human vitamin C transporter SVCT1 (SLC23A2) | 17.2 | 0 | 1 |
| Protection by aspirin of indomethacin-induced small intestinal damage in rats: mediation by salicylic acid | 17.2 | 0 | 1 |
| Interactions of aspirin and salicylic acid with prednisolone for inhibition of lymphocyte proliferation | 17.2 | 0 | 1 |
| pH-Metric logK calculations of famotidine, naproxen, nizatidine, ranitidine and salicylic acid | 17.2 | 0 | 1 |
| UV Erythema Reducing Capacity of Mizolastine Compared to Acetyl-salicylic Acid or both Combined in Comparison to Indomethacin† ¶ | 17.2 | 0 | 1 |
| Salicylic acid in soups prepared from organically and non-organically grown vegetables | 17.2 | 0 | 1 |
| Glucuronidation of the aspirin metabolite salicylic acid by expressed UDP-glucuronosyltransferases and human liver microsomes | 17.2 | 0 | 1 |
| Pharmacologic interventions in nuclear radiology: indications, imaging protocols, and clinical results | 17.2 | 0 | 1 |
| Zeta-crystallin displays strong selectivity for salicylic acid over aspirin | 17.2 | 0 | 1 |
| Efficacy and benefit of a 5-FU/salicylic acid preparation in the therapy of common and plantar warts--systematic literature review and meta-analysis | 17.2 | 0 | 1 |
| Prevention by parenteral aspirin of indomethacin-induced gastric lesions in rats: mediation by salicylic acid | 17.2 | 0 | 1 |
| Q28193537 | 17.2 | 0 | 1 |
| Salicylic acid reverses phorbol 12-myristate-13-acetate (PMA)- and tumor necrosis factor alpha (TNFalpha)-induced insulin receptor substrate 1 (IRS1) serine 307 phosphorylation and insulin resistance in human embryonic kidney 293 (HEK293) cells | 17.2 | 0 | 1 |
| Effects of vitamin C and aspirin in ischemic stroke-related lipid peroxidation: results of the AVASAS (Aspirin Versus Ascorbic acid plus Aspirin in Stroke) Study | 17.2 | 0 | 1 |
| Immediate treatment of frostbite using rapid rewarming in tea decoction followed by combined therapy of pentoxifylline, aspirin & vitamin C | 17.2 | 0 | 1 |
| Determination of aspirin and free salicylic acid in lysinipirine injection by high performance liquid chromatography | 17.2 | 0 | 1 |
| Fast and single solid phase fluorescence spectroscopic batch procedure for (acetyl) salicylic acid determination in drug formulations | 17.2 | 0 | 1 |
| Effect of castration on acetyl salicylic acid metabolism in rabbits | 17.2 | 0 | 1 |
| Administration-time dependent effects of acetyl-salicylic acid on blood pressure in patients with mild essential hypertension | 17.2 | 0 | 1 |
| Pharmacokinetic interaction study of a fixed combination of 500 mg acetylsalicylic acid/30 mg pseudoephedrine versus each of the single active ingredients in healthy male volunteers | 17.2 | 0 | 1 |
| Rofecoxib, as a safe alternative for acetyl salicylic acid/nonsteroidal anti-inflammatory drug-intolerant patients | 17.2 | 0 | 1 |
| Separation of salicylic acid drugs by aqueous and nonaqueous capillary electrophoresis with conductance detector | 17.2 | 0 | 1 |
| Preparation and evaluation of combination tablet containing incompatible active ingredients | 17.2 | 0 | 1 |
| Determination of free salicylic acid in chewing aspirin tablets by HPLC | 17.2 | 0 | 1 |
| Salicylic acid: an old dog, new tricks, and staphylococcal disease | 17.2 | 0 | 1 |
| Salicylic acid attenuates virulence in endovascular infections by targeting global regulatory pathways in Staphylococcus aureus | 17.2 | 0 | 1 |
| Effect of acetyl salicylic acid in drinking water on reproductive performance of Japanese quail (Coturnix coturnix japonica) | 17.2 | 0 | 1 |
| Case studies: Use of salicylic acid (Avosil) and hydrogel (Avogel) in limiting scar formation | 17.2 | 0 | 1 |
| Vitamin C losses in some frozen vegetables due to various cooking methods | 17.2 | 0 | 1 |
| Vitamin C transport systems of mammalian cells | 17.2 | 0 | 1 |
| Race-Specific Elicitors of Cladosporium fulvum Induce Changes in Cell Morphology and the Synthesis of Ethylene and Salicylic Acid in Tomato Plants Carrying the Corresponding Cf Disease Resistance Gene | 17.2 | 0 | 1 |
| Evaluation of the in vitro and in vivo antitumor activities of vitamin C and K-3 combinations against human prostate cancer | 17.2 | 0 | 1 |
| Skin care management: educational aspects | 17.2 | 0 | 1 |
| Emblica cascading antioxidant: a novel natural skin care ingredient | 17.2 | 0 | 1 |
| Role of vitamins in skin care | 17.2 | 0 | 1 |
| Minimally invasive total disc replacement: surgical technique and preliminary clinical results | 17.2 | 0 | 1 |
| Regulation of the human vitamin C transporters expressed in COS-1 cells by protein kinase C [corrected] | 17.2 | 0 | 1 |
| Differential expression of cornified cell envelope precursors in normal skin, intraorally transplanted skin and normal oral mucosa | 17.2 | 0 | 1 |
| Development of salicylic acid detector tube | 17.2 | 0 | 1 |
| Isochorismate synthase is required to synthesize salicylic acid for plant defence | 17.2 | 0 | 1 |
| Expression and characterization of vitamin C transporter in the human trophoblast cell line HTR-8/SVneo: effect of steroids, flavonoids and NSAIDs | 17.2 | 0 | 1 |
| Effect of salicylic acid on invasion of human vascular endothelial cells by Staphylococcus aureus | 17.2 | 0 | 1 |
| Homeopathy--what are the active ingredients? An exploratory study using the UK Medical Research Council's framework for the evaluation of complex interventions | 17.2 | 0 | 1 |
| The oxidation of glycolic acid by a liver enzyme | 17.2 | 0 | 1 |
| Effect of vitamin C-releasing acetylsalicylic acid on gastric mucosal damage before and after Helicobacter pylori eradication therapy | 17.2 | 0 | 1 |
| Circulating salicylic acid is related to fruit and vegetable consumption in healthy subjects | 17.2 | 0 | 1 |
| Salicylic acid, aspirin | 17.2 | 0 | 1 |
| Induction of HSP27 nuclear immunoreactivity during stress is modulated by vitamin C | 17.2 | 0 | 1 |
| False-Negative Stool Occult Blood Tests Caused by Ingestion of Ascorbic Acid (Vitamin C) | 17.2 | 0 | 1 |
| Salicylic acid-induced inactivation of creatine kinase in the presence of lactoperoxidase and H2O2 | 17.2 | 0 | 1 |
| In vitro enantioselective displacement of propranolol from protein binding sites by acetyl salicylic acid and salicylic acid | 17.2 | 0 | 1 |
| Semi-micro column high-performance liquid chromatography with UV detection for quantification of aspirin and salicylic acid and its application to patients' sera administered with low-dose enteric-coated aspirin | 17.2 | 0 | 1 |
| UGT1A6 polymorphism and salicylic acid glucuronidation following aspirin | 17.2 | 0 | 1 |
| Acetyl salicylic acid augments functional recovery following sciatic nerve crush in mice | 17.2 | 0 | 1 |
| Differences in the influence of the interaction between acetylsalicylic acid and salicylic acid on platelet function in whole blood and isolated platelets: influence of neutrophils | 17.2 | 0 | 1 |
| Measurement of salicylic acid in human serum using stable isotope dilution and gas chromatography-mass spectrometry | 17.2 | 0 | 1 |
| Relative bioavailability of salicylic acid following dermal application of a 30% salicylic acid skin peel preparation | 17.2 | 0 | 1 |
| Quantifying solubility enhancement due to particle size reduction and crystal habit modification: case study of acetyl salicylic acid | 17.2 | 0 | 1 |
| Synthesis and bioactivies of salicylic acid-g-chitosan derivatives | 17.2 | 0 | 1 |
| Clinical evidence for use of acetyl salicylic acid in control of flushing related to nicotinic acid treatment | 17.2 | 0 | 1 |
| Derivative-ratio spectrophotometric method for the determination of ternary mixture of aspirin, paracetamol and salicylic acid | 17.2 | 0 | 1 |
| Effects of salicylic acid on post-ischaemic ventricular function and purine efflux in isolated mouse hearts | 17.2 | 0 | 1 |
| The effects of acetylic salicylic acid on heart rate variability in healthy subjects | 17.2 | 0 | 1 |
| Salicylic acid regulates flowering time and links defence responses and reproductive development | 17.2 | 0 | 1 |
| The skin barrier as an innate immune element | 17.2 | 0 | 1 |
| Evidence-Based Skin Care Management in Radiation Therapy: Clinical Update | 17.2 | 0 | 1 |
| Expression of the homeobox gene HOXC4 in keratinocytes of normal skin and epithelial skin tumors is correlated with differentiation | 17.2 | 0 | 1 |
| Chemical peeling--glycolic acid versus trichloroacetic acid in melasma | 17.2 | 0 | 1 |
| Induction of hyaluronic acid synthase 2 (HAS2) in human vascular smooth muscle cells by vasodilatory prostaglandins | 17.2 | 0 | 1 |
| Filaggrin in the frontline: role in skin barrier function and disease | 17.2 | 0 | 1 |
| Dynamic cytoplasmic anchoring of the transcription factor Bach1 by intracellular hyaluronic acid binding protein IHABP | 17.2 | 0 | 1 |
| Massive doses of vitamin C and the virus diseases | 17.2 | 0 | 1 |
| A novel method to inject hyaluronic acid: the Fern Pattern Technique | 17.2 | 0 | 1 |
| Functional rescue of vitamin C synthesis deficiency in human cells using adenoviral-based expression of murine l-gulono-gamma-lactone oxidase | 17.2 | 0 | 1 |
| Cosmetic benefits of natural ingredients | 17.2 | 0 | 1 |
| New developments and novel therapeutic perspectives for vitamin C | 17.2 | 0 | 1 |
| Skin care practices for newborns and infants: review of the clinical evidence for best practices | 17.2 | 0 | 1 |
| Influence of facet and posterior muscle degeneration on clinical results of lumbar total disc replacement: two-year follow-up | 17.2 | 0 | 1 |
| Elevated blood histamine caused by vaccinations and Vitamin C deficiency may mimic the shaken baby syndrome | 17.2 | 0 | 1 |
| Purification and characterization of glycolic acid oxidase from pig liver | 17.2 | 0 | 1 |
| In Vitro Bioaccessibility of Carotenoids, Flavonoids, and Vitamin C from Differently Processed Oranges and Orange Juices [Citrus sinensis (L.) Osbeck] | 17.2 | 0 | 1 |
| Clinical results of Maverick lumbar total disc replacement: two-year prospective follow-up | 17.2 | 0 | 1 |
| Clinical results of charité lumbar total disc replacement | 17.2 | 0 | 1 |
| One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial | 17.2 | 0 | 1 |
| L-Gulono-1,4-lactone oxidase expression rescues vitamin C-deficient Arabidopsis (vtc) mutants | 17.2 | 0 | 1 |
| Evidence-based skin care management in radiation therapy | 17.2 | 0 | 1 |
| A C-terminal region dictates the apical plasma membrane targeting of the human sodium-dependent vitamin C transporter-1 in polarized epithelia | 17.2 | 0 | 1 |
| The repair of brain lesion by implantation of hyaluronic acid hydrogels modified with laminin | 17.2 | 0 | 1 |
| Intragenic deletion in the gene encoding L-gulonolactone oxidase causes vitamin C deficiency in pigs | 17.2 | 0 | 1 |
| The benefits of implementing a new skin care protocol in nursing homes | 17.2 | 0 | 1 |
| Clinical results of total lumbar disc replacement with ProDisc II: three-year results for different indications | 17.2 | 0 | 1 |
| The validity of skin care protocols followed by women with breast cancer receiving external radiation | 17.2 | 0 | 1 |
| Vitamin C elevates red blood cell glutathione in healthy adults | 17.2 | 0 | 1 |
| Does vitamin C supplementation influence the levels of circulating oxidized LDL, sICAM-1, sVCAM-1 and vWF-antigen in healthy male smokers? | 17.2 | 0 | 1 |
| The treatment of poliomyelitis and other virus diseases with vitamin C | 17.2 | 0 | 1 |
| Phase I trial of the oral antiangiogenesis agent AG-013736 in patients with advanced solid tumors: pharmacokinetic and clinical results | 17.2 | 0 | 1 |
| FURTHER OBSERVATIONS ON VITAMIN C THERAPY IN EXPERIMENTAL POLIOMYELITIS | 17.2 | 0 | 1 |
| Review: When is an antioxidant not an antioxidant? A review of novel actions and reactions of vitamin C | 17.2 | 0 | 1 |
| Spontaneous fractures in the mouse mutant sfx are caused by deletion of the gulonolactone oxidase gene, causing vitamin C deficiency | 17.2 | 0 | 1 |
| Evidence-Based Skin Care: A Systematic Literature Review and the Development of a Basic Skin Care Algorithm | 17.2 | 0 | 1 |
| Skin Care | 17.2 | 0 | 1 |
| Images in clinical medicine. Renal failure from vitamin C after transplantation | 17.2 | 0 | 1 |
| Regulation of UVB-induced IL-8 and MCP-1 production in skin keratinocytes by increasing vitamin C uptake via the redistribution of SVCT-1 from the cytosol to the membrane | 17.2 | 0 | 1 |
| Review of long-term adverse effects associated with the use of chemically-modified animal and nonanimal source hyaluronic acid dermal fillers | 17.2 | 0 | 1 |
| Reduction of anterior shoulder dislocations by Spaso technique: clinical results | 17.2 | 0 | 1 |
| Seasonal and climatic variation in cholesterol and vitamin C: effect of vitamin C supplementation | 17.2 | 0 | 1 |
| In vitro percutaneous absorption and in vivo stratum corneum distribution of an organic and a mineral sunscreen | 17.2 | 0 | 1 |
| Supplementation of vitamin C with atypical antipsychotics reduces oxidative stress and improves the outcome of schizophrenia | 17.2 | 0 | 1 |
| Erythrocyte Glut1 triggers dehydroascorbic acid uptake in mammals unable to synthesize vitamin C | 17.2 | 0 | 1 |
| Supplementation with cactus pear (Opuntia ficus-indica) fruit decreases oxidative stress in healthy humans: a comparative study with vitamin C | 17.2 | 0 | 1 |
| Vitamin C-aspirin interactions | 17.2 | 0 | 1 |
| An evaluation of the effect of an alpha hydroxy acid-blend skin cream in the cosmetic improvement of symptoms of moderate to severe xerosis, epidermolytic hyperkeratosis, and ichthyosis | 17.2 | 0 | 1 |
| The Infant Skin Barrier: Can We Preserve, Protect, and Enhance the Barrier? | 17.2 | 0 | 1 |
| CD47 expression in cryopreserved equine cutaneous masses and normal skin | 17.2 | 0 | 1 |
| Venomous bites and vitamin C status | 17.2 | 0 | 1 |
| Vitamin C: the dangers of calcium and safety of sodium ascorbate | 17.2 | 0 | 1 |
| How much vitamin C should I take | 17.2 | 0 | 1 |
| Homologous meniscus transplantation. Experimental and clinical results | 17.2 | 0 | 1 |
| Photoprotective and antiinflammatory effects of topical glycolic acid | 17.2 | 0 | 1 |
| Functional expression of sodium-dependent vitamin C transporter 2 in human endothelial cells | 17.2 | 0 | 1 |
| Assignment of cDNA Encoding Hyaluronic Acid-Binding Protein 1 to Human Chromosome 17p12–p13 | 17.2 | 0 | 1 |
| Natural ingredients for colouring and styling | 17.2 | 0 | 1 |
| Effects of high-dose B vitamin complex with vitamin C and minerals on subjective mood and performance in healthy males | 17.2 | 0 | 1 |
| Vitamin C Status of Melbourne Infants | 17.2 | 0 | 1 |
| Purification, partial characterization of rat kidney hyaluronic acid binding protein and its localization on the cell surface | 17.2 | 0 | 1 |
| Clinical results of enzyme replacement therapy in Fabry disease: a comprehensive review of literature | 17.2 | 0 | 1 |
| Genetic variation in the sodium-dependent vitamin C transporters, SLC23A1, and SLC23A2 and risk for preterm delivery | 17.2 | 0 | 1 |
| Vitamin C provision improves mood in acutely hospitalized patients | 17.2 | 0 | 1 |
| Vitamin C biosynthesis in prosimians: evidence for the anthropoid affinity of Tarsius | 17.2 | 0 | 1 |
| Vitamin C and cancer: what can we conclude--1,609 patients and 33 years later? | 17.2 | 0 | 1 |
| Vitamin C is not essential for carnitine biosynthesis in vivo: verification in vitamin C-depleted senescence marker protein-30/gluconolactonase knockout mice | 17.2 | 0 | 1 |
| Restoration of vitamin C synthesis in transgenic Gulo-/- mice by helper-dependent adenovirus-based expression of gulonolactone oxidase | 17.2 | 0 | 1 |
| Ascorbic acid as a sensor of oxidative stress and a regulator of gene expression: the Yin and Yang of vitamin C | 17.2 | 0 | 1 |
| Effects of vitamin C and vitamin D administration on mood and distress in acutely hospitalized patients | 17.2 | 0 | 1 |
| Progressive pseudogenization: vitamin C synthesis and its loss in bats | 17.2 | 0 | 1 |
| Thin-plate spline analysis of the effects of face mask treatment in children with maxillary retrognathism | 17.2 | 0 | 1 |
| The controversial place of vitamin C in cancer treatment | 17.2 | 0 | 1 |
| Beta IG-H3, a novel secretory protein inducible by transforming growth factor-beta, is present in normal skin and promotes the adhesion and spreading of dermal fibroblasts in vitro | 17.2 | 0 | 1 |
| Effect of simultaneous administration of vitamin C, L-cysteine and vitamin E on the melanogenesis | 17.2 | 0 | 1 |
| Effect of hypotonic 0.4% hyaluronic acid drops in dry eye patients: a cross-over study | 17.2 | 0 | 1 |
| A survey of skin problems and skin care regimens in the elderly | 17.2 | 0 | 1 |
| Sodium ascorbate (vitamin C) induces apoptosis in melanoma cells via the down-regulation of transferrin receptor dependent iron uptake | 17.2 | 0 | 1 |
| Articular Cartilage Regeneration With Autologous Peripheral Blood Progenitor Cells and Hyaluronic Acid After Arthroscopic Subchondral Drilling: A Report of 5 Cases With Histology | 17.2 | 0 | 1 |
| Vitamin C and the significance of that "wasted spillover" | 17.2 | 0 | 1 |